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Study of sulfonefluoresceine secretion in the cisplatin-treated rat kid-
ney. U. Ammer, Vu. Natochin, and K.J. Ullrich, Max Planck Institut
für Biophysik, Frankfurt, Germany; Sechenov Institute of Evolution
Physiology and Biochemistry of the USSR Academy of Sciences,
Leningrad, USSR. Cisplatin (CP) is a highly effective antitumor drug,
but its clinical use is limited by nephrotoxic effects. CP administration
is followed by morphological changes in the S3 segment of the rat
kidney proximal tubule. Previous investigations showed that CP is
secreted by the PAH transport system in the proximal tubule, and that
application of competitive inhibitors of PAH transport prevent nephro-
toxicity. An approach was developed to monitor renal tissue concen-
tration of sulfonefluoresceine (SF) (Steinhausen et al, Pflugers Arch
364:83—89, 1976) continuously. Secretion of SF was hampered by PAH
transport inhibitors (probenecid, tetrafluorosuccinate, apalcillin). After
a single injection of SF and '4C inulin to mactin anesthetized rats in
maximal mannitol diuresis, the excretion curve of both substances was
determined by 5 mm urine samples. CP pretreated rats (5 mg/kg body
wt, i.p. 5 days before the experiment) showed a reduced excretion of
inulin (by 38%) and SF (by 36%). SF tissue accumulation in CP animals
was similar to that of controls but lasted longer. Obviously, CP
treatment diminishes GFR and inhibits the luminal transport step in SF
secretion. The injection of diethyldithiocarbamate after CP treatment
reduced CP nephrotoxicity. With the new approach it is possible to
differentiate dysfunctions in organic anion transport beyond that ob-
tained by traditional clearance techniques.
Comparison of lactoferrin antibodies with myeloperoxidase or protein.
ase 3 antibodies (ANCA) in systemic diseases. S. Apenberg, M. GOtze, K.
Andrassy, E. Ritz, Department of Internal Medicine, Ruperto Carola
University, Heidelberg, Germany. Proteinase 3 antibodies (Pr 3) are
accompanied by a c-ANCA fluorescence pattern and are relatively
specific for Wegener's disease (WD). The p-ANCA pattern is caused by
myeloperoxidase (MPO), elastase and lactoferrin (L).ab. Whereas the
disease pattern accompanied by MPO-ab is relatively well character-
ized, information concerning elastase and L-ab are scarce. In the
present study on 378 patients [153 WD, 108 microscopic polyarteritis,
(MP) 63 SLE, 15 IgA-GN, 10 HSP, 9 PAN, 8 Sjogren's disease, 7 PSS,
5 Churg Strauss syndrome] screening for L-ab (and in parallel Pr 3-ab
and MPO-ab) was performed using a newly developed ELISA. Results:
Whereas Pr 3-ab and MPO-ab were present in approximately 90% of
WD and MP, respectively, L-ab were demonstrable only in 4/378
patients. All 4 positive patients presented with an overlap syndrome of
SLE or vasculitis, and had a typical p-ANCA pattern and MPO-ab in 3/4
cases. Conclusion: The highly specific demonstration of lactoferrin
antibodies is: (i) rarely positive in our experience; (ii) not associated
with a characteristic disease pattern; and (iii) not related to renal
functional prognosis.
REN-2 transgenic hypertensive rats—regulation of the renin system
under converting enzyme inhibition. S. Bachmann, M.A. Lee, D.
Ganten, and W. Kriz, Department of Anatomy and Cell Biology I, INF
307, Department of Pharmacology and German Institute for High
Blood Pressure Research, INF 366, Heidelberg, Germany. Transgenic
rats harboring the REN-2 gene of the mouse (TGRmRen2) were created
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as a model for the study of primary hypertension (Mullins et al, Nature
344, 541, 1990). Expression of the mouse-renin gene causes fulminant
hypertension (up to 260mm Hg). Plasma renin and angiotensin II values
are lowered, whereas plasma prorenin values are greatly increased.
Mouse renin in the adrenal gland is strongly overexpressed whereas in
the kidney, mouse and rat renin mRNA are decreased. In the study, 40
hypertensive TGRmRen2 rats were used (age 8 months, blood pressure
200 to 240 mm Hg before treatment). Three groups of 10 rats each
chronically received a converting enzyme inhibitor (lismnopril; CE!) in
doses of 0.5, 2 and 10 mg/kg/24 hr. Ten untreated rats served as
controls. Rats were kept in single cages for 6 weeks under daily blood
pressure control. Under CEI treatment (2 and 10 mg/kg only) blood
pressure decreased rapidly and remained low (140 mm Hg) during the
course of the study. Renin protein and renin mRNA in the juxtaglomer-
ular afferent arteriole were strongly increased in the treated animals
(immunocytochemistry, in situ hybridization). RNase protection assay
revealed CEL-induced stimulation of both the transgene and the endog-
enous renin gene. In the adrenal gland, however, the high expression of
the mouse renin gene was unchanged in all groups. These results show
that: (a) TGRmRen2 respond to CE! with high sensitivity; (b) in spite of
low renin and angiotensin plasma levels, blood pressure depends on the
conversion of angiotensin I to angiotensin II; and (c) CE! stimulates
expression of the transgene; thus the transgene is regulated in the
kidney, whereas in the adrenal gland it is constitutively expressed.
Interaction of thiazide and loop diuretics with the renal PAH transport
system. C. Bartel, C. Wirtz, E. Brdndle, J. Greven, institute of
Pharmacology, Medical Faculty, RWTH Aachen, Germany. The effect
of thiazide and loop diuretics on tubular 3H-PAH uptake was tested in
vitro on single S2 segments of the proximal tubule of rabbit kidneys.
Since the tubules were not perfused, and hence were collapsed, the
tubular 3H-PAH uptake reflects 3H-PAH transport across the contralu-
minal membrane. The diuretics were added to the bath solution in at
least 6 (maximum 9) different concentrations, The concentration of
3H-PAH in the bath solution amounted to 1.3 mol/liter, and hence was
12 times lower than the PAH concentration (16 mol/l) at half-
maximum PAH uptake. In accordance with the studies of Ullrich et al
(Kidney mt 36:78—88, 1989) lipophily and electrical charge of the
diuretics influenced the affinity to the PAH transport system. For the
different diuretics the following concentrations were determined at
which the 3H-PAH uptake was half-maximally inhibited (IC50 values, all
date in mol/liter): bumetamide 3, xipamide 8, azosemide 21, piretanide
28, furosemide 40, hydroxychlorothiazide 140. The IC50 value for
probenecid, the classical inhibitor of tubular PAH secretion, was 1.7
smol/liter. All diuretics and probenecid stimulated (.'z10_6 M) the PAH
uptake at low concentrations. It is concluded that hydrophobicity and
electrical properties of the diuretics are important parameters which
determine the affinity to the PAH transport system.
Continuous noninvasive blood pressure monitoring during dialysis. P.
Baumgart, A. Raffelsiefer, V. Laske, K.H. Rahn, Medizinische Polik-
linik, University of Muenster, Muenster, Germany. Blood pressure can
now be recorded beat-to-beat by a novel noninvasive method (finger-
light-pletysmometry, Finapres'). We studied the utility and practicality
of this procedure for monitoring of dialysis. In 29 hospitalized patients
with hypotensive episodes during previous dialyses, intermittent and
continuous BP recordings were performed simultaneously during 2
subsequent and comparable hemodialyses. Intermittent readings were
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taken oscillometrically (DinamapR) every 15 minutes at the upper arm;
continuous recording (FinapresR) was performed at the equilateral
middle or index finger. Decisions for antihypotensive intervention
during dialysis were based on intermittent monitoring in one dialysis
and on continuous monitoring in the other. These correctional measures
(by situation: reduced filtration, supplementation of NaCl/volume) were
taken if systolic BP was <100 mm Hg at intermittent monitoring and if
finger BP was <100 mm Hg at continuous BP control. In all patients,
continuous finger blood pressure monitoring could be performed during
entire dialysis (3—5 hrs) while cuffs were switched hourly between
middle and index fingers. There were 17 symptomatic hypotensive
episodes in 11 of the 29 patients during dialysis control by intermittent
BP readings. With BP control by continuous reading there were only 9
hypotensions in 4 of the 29 patients. Hence continuous BP recording
during dialysis by the FinapresR method is feasible. Impending hypo-
tension may be prevented by earlier detection. This novel procedure is
of particular value in patients with habitual hypotension during dialysis.
Renal function, circulatory parameters and proteinuria in living-
related kidney donors before and after exercise. Chr. Blaser, J.E.
Scherberjch, E. Scheuermann, W. Ernst, W. Schoeppe, Department of
Medicine, University of Frankfurt/M., Frankfurt am Main, Germany.
We investigated possible changes of renal function (creatinine clear-
ance, Car), routine blood parameters, blood pressure and the excretion
of tubular enzymes and serum proteins after unilateral nephrectomy of
33 related donors (20 f, 13 m, 5.35 years after nephrectorny) before
and after a standardized 6 mm exercise. For comparison, we examined
28 healthy persons with two kidneys (17 f, II m) in the same manner.
Two urine samples of collecting periods of I hr, one before and one
after exercise, were analyzed. The kidney size and the diameter of the
parenchyma, measured by ultrasound, were larger in the nephrecto-
mized patients (2P < 0.05—0.001); the median of serum creatinine was
higher (2P < 0.001), the endogenous creatinine clearance lower (2P <
0.01), serum K, Ca and glucose concentrations were higher (2P <
0.01); all were within normal limits, however. After exercise the donors
had higher excretion rates for albumin, alpha-l-microglobulin and
/3-NAG, with a positive correlation between /3-NAG and albumin
excretion (calculated as protein/creatinine index, 2P < 0.05). After 6
mm of exercise and after 5 mm of regeneration, the heart rate of the
donors was significantly higher compared to the controls, as was the
blood pressure before and after exercise (2P < 0.05—0.01), The protein
excretion patterns (SDS-PAGE) showed more protein bands in the
donors's specimens vs. control after exercise. These data evidence
changes of renal function and protein handling in the kidney donor
group under exercise compared to the controls, apparently reflecting
adaptive responses which were all within physiological ranges.
Leukocyte kinetics during plasmapheresis with four different mem-
branes. J. Böhler, W.H. HOn. K. Dern, W. KOster, P.J. Schollmeyer,
Department of Nephrology, University of Freiburg and University of
Homburg/Soar, Germany. Leukocyte counts during hemodialysis un-
dergo dramatic changes depending on the membrane material used.
Plasma separation procedures also utilize artificial polymeric mem-
branes, but little is known about their bioconipatibility. We studied 4
plasmapheresis membranes in a group of patients (N = 7) with familial
hypercholesterolemia treated with a lipid removing procedure (HELP:
heparin-induced extracorporeal LDL-precipitation) which involves
membrane plasma separation. Complete blood counts were done before
and repeatedly during plasmapheresis in blood from the afferent blood
line.





















a P < 0.05 vs. 0 mm
After 60 mm a profound granulocytopenia had developed with a nadir of
33% for PE, 44% for PMMA, 81% for PP and 84% PS compared to
pretreatment levels. At 120 mm a rebound of granulocyte counts and
even an overshoot reaction was observed. Because the processing of
the apheresed plasma by the HELP procedure was identical in all
treatments, we conclude that the differences in leukocyte kinetics are
due to the plasma separation membrane material. Activation of immune
system components is highly undesirable, particularly in patients with
immunological disease, and bioincompatibility needs to be considered
when choosing a membrane.
Effect of 1,25-vitamin D3 (1,25D3) on intracellular calcium [Ca]1 in
mesangial cells (MC). R. Boland, A.de Boland, T. Weinreich, R.
Nobiling, E. Ritz, Department of Biology, Universidad del Sur, Bahia
Blanca (ARG), Ins titut of Physiology and Department of Internal
Medicine/Nephrology, University of Heidelberg, Heidelberg, Ger-
many. After characterization of a specific 1 ,25D3 receptor in human
MC, we investigated the effects of l,25D3 on rapid changes in [Ca]1 in
MC, as was recently demonstrated for other cells. Primary cultures of
human and rat MC were subcultured on glas coverslides. [Ca]1 was
measured by microfluorospectrometry of fura-2 loaded MC (0.5 g, 20
mm; single cell analysis). For experiments MC were exposed to
different vitamin D metabolites (1,25-; 24,25-; 25D3) or vehicle in tyrode
solution for 15 mm. Excitation wavelength was 340 and 360 nm (filter
exchange 100/sec; mercury lamp). Emission was monitored at 500 nm
and computer assisted analyzed. Thirty-five to 40% of MC showed a
rapid increase in [Ca], (65 to 280% of contr.) under l,25D3 (l0_b0l0_7
M), which persisted over the time of observation. The effect was dose
dependent and paralleled those seen with the Ca channel agonist Bay K
8644 (2 M). Increase in [Cal with 25D3 was about 50% less than with
1 ,25D3. Other metabolites had no effect. Nifedipine (2 tM) and COCI2
(1 mM) inhibited the increase of [Ca] by 80%. Similar results were seen
when measuring 45Ca uptake in MC monolayer. These data point to a
rapid, nongenomic effect of l,25D3 in MC, probably by activation of
voltage-dependent Ca channels.
Affinity of different local anesthetic drugs and catecholamines to the
contraluminal transport system for organic cations in proximal tubules of
rat kidneys. E. Brdndle, G. Fritsch, J. Greven, K.J. Ulinich, Depart-
ment of Pharmacology, Aachen, and MPJ für Biophysik, Frankfurt,
Germany. The transport system for organic cations in renal proximal
tubules is an important site for xenobiotic elimination. However, only
little information is available on the molecular requirement of a sub-
stance which is transported by this system. To study the cellular uptake
of 3H-TEA (tetraethylammonium) and its inhibition by different local
anesthetic drugs and catecholamines, the capillary stopped-flow mi-
croperfusion method described by Ullrich et al (Pflugers Arch 400:250—
256, 1984) was used. 3H-TEA concentration in the peritubular capillar-
ies decreased in a time and concentration dependent manner. This
cellular uptake of 3H-TEA could be described by a facilitated diffusion
model (max = 0.57 0.08 pmol sec cm, Km = 0.28 0.01
mmol/liter). Between the PKa values of the local anesthetic drugs
(range: 2.8 and 8.9) and their app. K, values a significant correlation was
found (r —0.916, N = 12). Hydrophobic substitution in form of an
alkyl chain in alpha position or at the nitrogen increased the inhibitory
potency of the catecholamines, while hydroxyl substitution in beta
position decreased the affinity. In contrast, however, the app. K, values
of catecholamines with complex substitutions at the benzene ring
(-CH2OH,-NHCONH2, -OOCN[CH3}2, -Cl,-NH2) were not directly
correlated to the hydrophobicity. Conclusions: The hydrophobicity and
the PKa value are two important physiochemical parameters which
influence the affinity of a molecule to the transport system for organic
cations at the contraluminal side of renal proximal tubules. However,
the different inhibitory potency of catecholamines with complex sub-
stitutions at the benzene ring could not be explained by these parame-
ters.
Halt of the progression of nephropathy in type I and type 2 diabetic
patients by antihypertensive treatment with nitrendipine. R.G. Breizel,
C. Bollen, E. Maser, K. Federlin, 3rd Medical Clinic and Policlinic,
University of Giessen, Germany. The progression of diabetic microal-
buminuric nephropathy may be successfully influenced by antihyper-
tensive treatment. Due to their hemodynamic effects, calcium channel
blockers have not been recommended for diabetics in this situation.
But, long-term studies in a homogenous cohort are presently unavail-
able. Therefore, we studied, in an open 12-month trial in 25 type I and
type 2 diabetics with mild hypertension and microalbuminuria, the
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effects of the calcium channel blocker, nitrendipine, on blood pressure
(BP), albuminuria (ALB), glomerular filtration rate (GFR), and renal
plasma flow (RPF), as well as the effects on glucose and lipid metabo-
lism. The study will end in October 1991; currently, twelve patients (6
type 1 and 6 type 2 diabetics) have already reached the end-point of the
investigation period. Their parameters at the start and end of the study
are as follows: BP 155 91 vs. 127 79 mm Hg; ALB 75 13 vs. 31
4 mg/24 hr; GFR 108 10 vs. 125 10 mi/mm; RPF 488 48 vs. 438
35 mI/mm. The effect on microalbuminuria is obviously not a
consequence of glucose control (HbAl 11.7 0.5, vs. 11.0 0.6%).
Lipid profiles and the residual C peptide secretion remained unchanged.
This study demonstrates for the first time that the progression of
nephropathy in type 1 and type 2 diabetic patients can be stopped by
treatment with a dihydropyridin-type of calcium channel blocker (ni-
trendipine). No adverse effects on glucose and lipid metabolism were
observed.
Inhibition of biological actions of angiotensin II (Ang II) in human
mesangial cells by non-peptidic receptor antagonists of Ang LI-i. S.
Czekalski, D. Chansel, R. Ardaillou, U64 INSERM, Paris, France and
Clinic for Endocrinology and Metabolic Disease, Szczecin, Poland.
The aim of the present study was to assess the effects of inhibition of the
biological action of Ang II in human mesangial cells using specific
non-peptidic receptor antagonists of Ang 11 subtype I: DUP 753 and
EXP 3174. We examined the effects of these antagonists at 10_4_10_b0
mol/liter on Ang II induced increments of intracellular calcium, PGE2
production and protein synthesis. Both antagonists blocked the incre-
ment in intracellular calcium concentration over a wide range of
concentrations. Ang II dependent production of PGE2 was blocked by
increasing doses of both antagonists. Fifty percent inhibition was seen
at 1 nmol/liter EXP 3174 and 0.3 mol/liter DUP 753. Both antagonists
inhibited Ang II and protein synthesis measured as 3H-leucine incorpo-
ration in mesangial cells. The results document that non-peptidic Ang II
receptor antagonists subtype Ang IL-I inhibit the major biological
effects of Ang II on human mesangial cells.
Lipid peroxidation—A potential atherogenic risk factor in hemodialysis
patients. W.H. Daerr and S. Grosser, Medizinische Kern-und Poliklinik
des Universitätskrankenhauses Eppendorf, Hamburg, Germany. Ath-
erosclerotic vascular disease (AVD) is the leading cause of death in
hemodialysis (HD) patients. Among the factors implicated in initiation
and progression of AVD-enhanced lipid peroxidation may have a major
role. Therefore, lipid peroxides (LPs) were determined in whole serum
and in individual lipoprotein fractions of 58 HD patients and 58 normal
subjects with no history of renal disease, matched for age, sex, smoking
habits and serum lipid levels. Thiobarbituric acid was used to assay LPs
through detection of malondialdehyde. Groups were compared using
the Wilcoxon unpaired statistics. There were no differences in LPs of
whole serum, LDL and HDL between HD patients and controls. By
contrast, LPs were significantly increased per mg of VLDL protein in
HD patients (0.81 1.06 nmol vs. 0.43 0.44 nmol; P < 0.05).
Furthermore, VLDL LPs decreased significantly during 2 hr HD (0.47
0.48 nmol/mg; P < 0.05). These results show that lipid peroxide
formation is enhanced in HD patients. Results are compatible with a
heparin-induced accelerated catabolism of peroxidized VLDL in these
patients.
Substrate specificity of the luminal Na-dependent sulfate/oxalate
transport system in the proximal tubule of the rat kidney as compared to
the contraluminal sulfate/oxalate exchange system. C. David, K.J. UI/-
rich, Max-Planck-Instijut für Biophysik, Frankfurt/Main, Germany.
The substrate specificity of the contraluminal sulfate/oxalate exchanger
has been extensively studied (Ullrich KJ et al, Pflugers Arch 404:307—
310, 1985; 404:311—318, 1985), but there is little information about that
of the luminal sodium-dependent sulfate/oxalate transport system. By
using the stop-flow microperfusion method (E. Sheridan et al, Pflugers
Arch 399:18—28, 1983) different substances were tested in the in situ rat
kidney preparation. The evaluated luminal K1 values and the published
contraluminal K, values were compared with each other. Dependent on
the degree of inhibition, three distinct groups of test substances were
found. A nearly 1:1 K, luminal/K, contraluminal ratio was found for
sulfate, thiosulfate, selenate, molybdate and phosphate. A K1 ratio
between 3 and 10 held for oxalate, bicarbonate, probenecid and
H2-D1DS. No luminal inhibition was seen with bromphenol blue,
phenol red, fluoresceine and furosemide, although these substances
exerted strong contraluminal inhibition. The results indicate that small
molecules interact with both luminal and contraluminal sulfate/oxalate
transport systems with the same affinity, while bigger molecules show a
weak or no interaction with the luminal sulfate transport system. It is
suggested that both transport systems have comparable molecular
structures.
VLA al-n6 and aV integrins in glomerulonephritis. S. Cuzic, I.L.
Noronha, R. Waldherr, Department of Pathology, University of
Heidelberg, Germany. Integrins are a family of cell surface proteins
that are involved in cell-cell adhesion and cell-extracellular matrix
interactions. They are membrane glycoproteins consisting of two non-
covalently associated subunits, a and /3. One class of integrins is
comprised of unique a chains complexed to a common /31 chain. We
examined normal kidney tissue and 40 renal biopsies from patients with
various forms of glomerulonephritis (GN) by immunocytochemistry
(APAAP method) using monoclonal antibodies against al (VLA1)
(clone TS2/7), a2 (VLA2)-CDw49b (clone Gi9), a3 (VLA3)-CDw49c
(clone P1BS), a4 (VLA4)-CDw49d (clone HP2/l), aS (VLA5)-CDw49e
(clone SAMI), a6 (VLA6)-CDw49f (clone GoH3) and av-CD51 (Vit-
ronectin receptor, clone AMF7): IgA GN (N = 10), membranous GN(N = 10), minimal change (N = 10), focal glomerulosclerosis (N = 5),
acute GN (N = 5). In normal kidneys (N = 5), mesangial cells were
VLA al, VLA a2, and weakly VLA aS positive. Podocytes expressed
VLA a3 and av, capsular epithelial cells VLA al, VLA a3 and av.
Glomerular endothelial cells as well as endothelial and myointimal cells
of interstitial vessels were positive for VLA a3. All tubules showed a
marked staining for VLA a6 at the basal membrane junction. In
addition, distal tubules were positive for VLA al, VLA a2, VLA cx3
and av. Compared to normal kidneys, no change in the glomerular
staining pattern for VLA a2—a6 was observed in IgA GN, acute GN,
and in the majority of cases with minimal change nephrotic syndrome.
In cases with mesangial enlargement VLA al expression was in-
creased. In membranous GN and focal glomerular sclerosis mesangial
cells showed a decreased reactivity for VLA a2 and/or VLA aS; in focal
glomerular sclerosis VLA al expression was decreased. In the majority
of these biopsies, tubules were negative for VLA a6. Reduced staining
for av was observed in podocytes and distal tubular epithelial cells in
focal glomerulosclerosis and acute GN. Cellular crescents in IgA GN
and acute GN were positive for VLA a3 and av, fibroblasts in
fibrocellular crescents expressed VLA a2, VLA aS and av. Sclerotic
glomeruli and areas of segmental glomerular sclerosis were completely
negative. Our results demonstrate that there is an altered expression of
integrin receptors on glomerular cells and tubular epithelial cells in
some forms of glomerulonephritis. The modification of integrin expres-
sion may be important for the understanding of cell-matrix interactions
in these conditions.
Albumin binding in chronic renal failure—Inhibition by endogenous
inhibitors and structural modifications. T.J. Den gler, C.-M. Robertz-
Vaupel, and H.J. Dengler, Medizinische Universitatsklinik, Bonn-
Venusberg, Germany. The binding capacity of human serum albumin
(HSA) for small acidic molecules is known to be reduced in chronic
renal failure. This study evaluates the contribution of competitive
inhibition by accumulated endogenous ligands and of structural changes
of HSA. In a fluorimetric in vitro test assay with HSA (5 /.Lmol/liter) and
two dansylated amino acids (1 mol/1iter), the inhibitory properties of
various endogenous ligands were determined in concentration-effect
curves. The effect of carbamylation of HSA on binding was also
studied. The respective mode of inhibition including binding parameters
n and Ka was determined. Finally, the binding capacity of HSA in sera
of controls and dialysis patients was compared using the test system.
Thirty-four substances were tested: Comparable strong inhibition
(>50%) was shown, for example by indolyl acids, cinnamic acid and
furanoic acids, medium inhibition (10—50%), for example by vanillic
acid, whereas urea, creatinine, uric acid and guanidine compounds had
no effect. The mode of inhibition was purely competitive except for the
furanoic acids. Carbamylation of HSA reduced binding by 68% in a
non-competitive mode. The serum experiments showed a reduction of
HSA binding capacity in the dialysis patients of 24% irrespective of
medication (P < 0.001). Conclusion. The binding defect of HSA in CRF
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is caused by the combined action of many endogenous ligands and
structural modifications of HSA. The presented test system is useful for
rapid analysis of possible inhibitors and for testing large patient groups
(comparison of dialysis treatments, pharmacological binding studies).
TNFa plasma levels after renal transplantation. S.F. Dorge, G.
Lonnemann, R. Schindler, K.M. Koch, U. Frei. Department of
Nephrology, Medizinische Hochschule Hannover, Hannover, Ger-
many. TNFa serum levels were found to be elevated in renal transplant
recipients undergoing rejection (Maury et al 1987), However, more
recent data could demonstrate an artificial increase in TNFa serum
levels due to an ex vivo stimulation of monocytes (Freeman et a!,
Lancet 1990). To address the question of whether serial TNFa deter-
minations are helpful with the differential diagnosis or even prediction
of acute rejection, blood samples were obtained preoperatively and
daily during the first four weeks after transplantation in 27 patients.
Blood was drawn into sterile tubes containing EDTA (1.5 mg/mI) and
aprotinine (0.67 TIU/ml). Platelet-depleted plasma was separated within
90 minutes and stored at —70°C until assayed. This method largely
prevents cx vivo stimulation effects. The detection limit of the assay
(TNFs IRMA, Medgenix) is 5 pg/mI. Creatinine (Crea) and cyclospo-
rine (C5A) serum levels were monitored as routine parameters. Epi-
sodes of acute rejection were confirmed bioptically. In 203 of 385
samples obtained from 16 patients with an uncomplicated postoperative
course TNFa, plasma levels were below the detection limit of the
assay, 95% of values were below 8.4 pg/mI, respectively. Values higher























Following this study, TNFa plasma levels in the early postoperative
course were found to be within the borderline range with respect to the
assay's detection limit. Increases in TNFa plasma levels had a sensi-
tivity of 40—60% up to 4 days before rejection became clinically
apparent. Although our data suggest a possible discrimination between
cyclosporine toxicity and rejection, the sensitivity for the detection of
acute rejection episodes is too low to recommend TNFc determinations
in plasma as a reliable parameter for routine follow up.
Age dependent expression of the erythropoietin gene in rat liver and
kidneys. K.-U. Eckardt, C.C. Tan, P.J. Ratclffe, and A. Kurtz,
Department of Physiology, University of Regensburg, Germany, and
Institute of Molecular Medicine, John Radcljffe Hospital, Oxford,
United Kingdom. The major control mechanism for the oxygen depen-
dent production of erythropoietin (EPO) operates at the level of its
mRNA. To assess age-related changes in the contribution of liver and
kidneys to EPO formation, we used a quantitative RNAse protection
assay to determine EPO mRNA concentrations in rat liver and kidneys
during postnatal development (days I to 54) under unstimulated condi-
tions, and after exposure to normobaric hypoxia or carbon monoxide
(functional anemia). Hepatic EPO mRNA concentrations in unstimu-
lated rats were maximal on day 1 and became too low for quantitation
between days 14 and 28. Following stimulation, EPO mRNA was
quantifiable in the liver at all ages, but was up to 10-fold lower in adults
than in neonates. In kidneys of unstimulated rats, EPO mRNA was also
maximal in neonates, but remained quantifiable until adulthood, where
it was 5-fold lower than on day I. In contrast, under stimulation, renal
EPO mRNA concentrations increased up to 7-fold between days I and
54. When differences in organ weight were taken into consideration, the
ratio of the total amount of EPO mRNA in liver and kidneys was similar
for both types of stimuli, but decreased with age. Within the first three
weeks, the liver contained the majority of total EPO mRNA in both
stimulated and unstimulated animals. Although the hepatic EPO mRNA
contribution in stimulated animals declined with development, from a
maximum level of 85% on day 1, it still accounted for about 30% of the
total at day 54. When related to body weight the total amount of EPO
mRNA in stimulated animals, that is, the sum of renal and hepatic EPO
mRNA, either decreased with age (normobaric hypoxia) or remained
constant (carbon monoxide). Serum EPO levels under both stimuli,
however, increased 2- and 12-fold between days I and 54, respectively.
In conclusion, the data suggest that in rats: (i) the dominant site of EPO
formation shifts gradually from the liver to the kidneys during postnatal
development, (ii) the hepatic contribution to EPO formation remains
substantial and surprisingly high up to adulthood and (iii) a dispropor-
tionality occurs, with age, in the relationship between EPO mRNA and
serum hormone concentrations, which may be due to changes in
translational efficacy or EPO metabolism.
Modulation of renal function by endogenous dopamine in conscious
dogs. H. Ehmke, PB. Persson, R. Girchev, H.R. Kirchheim, 1. Phys-
iologisches Institut, Universitat Heidelberg, Heidelberg, Germany.
Dopamine (DA) is an important neurotransmitter abundantly present in
the central nervous system. Accumulating evidence suggests that
dopamine may act additionally as a paracrine substance in the kidney:
DA1-and DA2-receptors are present in the renal vasculature, glomeruli,
and tubuli, the kidneys are capable of synthesizing DA from circulating
L-dopa, and infusions of DA can significantly increase sodium excre-
tion. Thus DA may be a potent endogenous natriuretic substance. In the
present study, the importance of DA for the regulation of renal function
was investigated in 6 conscious dogs under resting conditions and
during an acute increase in blood pressure by common carotid occlu-
sion (CCO). The dogs were fed a normal salt diet (100-1 10 mmol
Nat/day). In group I, the renal dopamine system was intact, while in
group lIthe DA1/DA2-antagonist Flupentixol (4 pg/kg/mm) was infused
intrarenally, which minimized systemic effects. A chronic ureter cath-
eter allowed rapid and selective collection of urine from the experimen-
tal kidney; renal blood flow (RBF) was determined by an electromag-
netic flow probe implanted around the renal artery. In both groups,
CCO increased blood pressure by 30 mm Hg and induced a pressure
natriuresis (+41%). At both pressure levels, Flupentixol significantly
reduced absolute (—42%) and fractional (—33%) sodium excretion
without affecting RBF, glomerular filtration rate, filtration fraction, or
potassium excretion. These data indicate that in conscious dogs on a
normal salt intake endogenous DA exerts a strong tonic influence on
sodium excretion over wide range of renal perfusion pressure. Elevated
concentrations of DA shift the pressure-natriuresis relationship to lower
pressure levels. A defective renal dopamine system will cause fluid
retention, which may ultimately result in an increased blood pressure.
This study was supported by the Deutsche Forschungsgemeinschaft
within the Forschergruppe Niere.
The outflow segment of the glomerular efferent arteriole in rat. M.
Elger, D. Winkler, S. Wirth, and W. Kriz, Anatomy and Cell Biology,
University of Heidelberg, Heidelberg, Germany. To elucidate in more
detail the structure of glomerular arterioles at the entrance of the
glomerulus, a combined light, electron and immunofluorescence micro-
scopic study was undertaken. Immediately after its entrance into the
glomerulus, the afferent arteriole (AA) splits into large branches which
have the wall structure of glomerular capillaries. The efferent arteriole
(EA), in contrast, is established inside the glomerular tuft. Thus, the EA
has an intraglomerular segment (IGS) traversing the mesangial stalk,
followed by a segment passing through the extraglomerular mesangium.
The IGS and the final portions of its tributaries are completely embed-
ded in the mesangium. The IGS is characterized by an unfenestrated
endothelium with a high number of endothelial cell bodies. The endo-
thelial tube is fully surrounded by a mesangial layer. At the final
confluence of tributaries, smooth muscle cells appear, which subse-
quently develop into a complete layer around more downstream por-
tions of the EA. The entire outflow segment is prominent by its narrow
lumen. The hydrostatic pressure in the mesangium is suggested to range
in the same magnitude as that in the glomerular vessels (Kriz et al,
Kidney mt 38:S2—S9, 1990). Given this condition, the structural ar-
rangement at the vascular pole provides the possibility that the pressure
in the AA (PA) influences the resistance of the EA. An increase in A
will raise the pressure in the glomerular capillaries, in the EA (PE), and
in the mesangium (PM). 'M andPchange in parallel with an increase
or decrease of A' the system will tend to keep the resistance of the IGS
constant. However, if a rise in A will cause a higher increase in M
than in P, the efferent resistance will increase with an increase in
Enhanced blood pressure responsiveness to mineralocorticoid in off-
spring of hypertensive parents. P. Ferrari, M. Travaglini, C. Schild, Y.
Allemann, S. Shaw, P. Weidmann, Med. Universitdts-Poliklinik, Bern,
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Switzerland. Currently, normotensive offspring of essential hyperten-
sive parents often have disturbances in blood pressure (BP) regulation,
such as abnormalities in electrolyte homeostasis, increased salt sensi-
tivity and/or impaired renal Na excretion. Whether an altered reactiv-
ity to mineralocorticoids may also play a role is presently unknown.
Therefore, we investigated BP (recorded during 24 hr), plasma atrial
natriuretic factor (ANF), aldosterone (PA) and renin activity (PRA),
urinary electrolyte excretion measured on 4 consecutive days, as well
as other variables, after I week on placebo and after 3 weeks of
9a-fludrocortisoneacetate (9aF) administration, 0.6 mg/day, in 12 nor-
motensive Sons of essential hypertensive parents (SEH) and 12 body
mass index and age-matched [24 I (±sEM) yrl sons of normotensive
parents (SN). On placebo, the 2 groups did not differ significantly in
average 24-hr BP (mean BP 95 2 vs. 95 2 mm Hg), plasma ANF (40
7 vs. 30 5 pg/ml), PRA(l.3 0.1 vs. 1.6 0.2 nglmllhr), PA(9
0.5 vs. 10 0.9 ng/dl), hematocrit (44 0.7 vs. 44 0.4%) and 96-hr
urinary Na (mean 205 13 vs. 195 16 mM/day) or K (69 6 vs. 78
7 mM/day). 9aF significantly increased BP in SEH (P < 0.005) but not
SN (107 2 vs. 100 2 mm Hg, P < 0.05). BP elevation during the
night in SEH accounted for this difference (+13 vs. +8 mm Hg, P <
0.02). However, during 9aF the 2 groups did not differ with regard to
plasma ANF (106 13 vs. 100 14 pg/mI), PRA (0.5 0.1 vs. 0.5
0.2 ng/ml/hr), PA (5 0.3 vs. 4 0.3 ng/dl), 96-hr urinary Na (205
19 vs. 195 17 mM/day) or K (80 8 vs. 69 6mM/day), plasma Na
(increase +3 vs. +2 mM/liter) or K (decrease —0.5 vs. —0.5 mM/liter),
hematocrit (42 0.8 vs. 42 0.2%) or body weight (increase +2.0 vs.
+ 1.9 kg). These results indicate that normotensive offspring of hyper-
tensive parents respond to mineralocorticoid stimulation with an en-
hanced BP increase. This disturbance cannot be explained by insuffi-
cient renin-aldosterone suppression, inadequate ANF stimulation or
abnormally increased Na fluid retention.
Detection of IL-6, GM-CSF and PDGF-B in cultured human renal
epithelial cells. J. Frank, G. Engler-Blum, H.P. Rodemann, and GA.
Muller, Medical University Clinics, Eberhard-Karts-University Tilbin-
gen, Tubingen, Inst. of Developmental Biology, Bielefeld, Germany.
The progression of renal diseases which is associated with a decline of
excretory renal function is often based on the development of renal
interstitial fibrosis (RIF). Growth factors are probably involved in the
pathogenesis of RIF. Therefore, we analyzed the transcription of
several cytokines in cultured renal epithelial cells (mainly tubular
epithelial cells) of passages 2 and 3. The cell cultures were established
from 9 renal biopsies with different forms of glomerulonephritis and
from 1 normal cadaver kidney offered for transplantation. RNA was
isolated from cells which were in logarithmic growth. The following
c-DNA probes were used for northern blot hybridizations: IL-la,
IL-1J3, IL-6, INF-y, TNFa, a-FGF, b-FGF, GM-CSF and PDGF-B.
The renal epithelial cells showed a strong signal for IL-6 and PDGF-B,
whereas GM-CSF was only weakly expressed. The RNA of the other
growth factors tested so far were not transcribed by these cells. In
colony stimulating assays using human bone marrow cells, we were
able to demonstrate that human renal epithelial cells in culture secrete
factors which stimulate hematopoetic progenitor cells to divide and to
differentiate. These data are in accordance with our results obtained
from Northern blot hybridizations. Extended analyses are currently
performed to analyze the influence of these growth hormones on the
proliferation rates and differentiate stages of renal fibroblasts which are
mainly involved in forming RIF.
Experimental investigations into the pathogenesis of dysmorphic eryth-
rocytes in glomerulonephritis (GN). R. Funfstuck, K.-J. Halbhuber, B.
Kuhn, R. Kuhn, M. Klinger, H. Oehring, and G. Stein, Departments of
Medicine and Anatomy, University of Jena, Jena, Germany. Nineteen
patients (pts) underwent renal biopsy because of GN (dysm. cry, in
urine 77 8%). The glomeruli had thickened basal laminae and
hydropic swellings of the endothelial cells, which surrounded the intact
ery. Intraluminal cry. in the tubules showed floccular cytosol, suggest-
ing hemolysis. Polariscopically, we found glycocalyx changes with an
anisotropy of the cry. in glomerular capillaries (32 5 nm), in the
tubules (22 6 nm) and in the urine (21 6 nm). Membrane damage
was reflected in an increased binding of autologous IgG. Experimen-
tally, typical dysm. cells were produced after surface alteration with
trypsin (12 2%), papain (35 2%), chymotrypsin (36 6%) and
pronase (37 4%) with subsequent incubation of these damaged cells in
urea-containing hyposmotic environment (urea 40 mmollliter; 70
mOsmlkg). There is a positive correlation between the degree of
dysmorphogenesis as well as the extent of surface destruction and the
urea concentration with low osmolality. As to their properties, such
cry. correspond to dysm. cells in urine as in GN. Gel electrophoresis
documented a spectrin deficiency of these altered cells. On this basis it
is likely that a damage of ery. starts in the glomeruli (glycocalyx
destruction), and is completed by osmotic as well as urea effects
(hemolysis, spectrin losses) in the tubular system.
Impaired platelet thrombospondin (TSP) release in chronic hemodial.
ysis (HD) patients. M.P. Gawaz, R.A. Ward, and H.J. Gurland,
Nephrology Department, University of Munich, Munich, Germany and
Division of Nephrology, University of Louisville, Louisville, Kentucky,
USA. Thrombospondin (TSP), an adhesive glycoprotein, is stored in
platelets and plays a crucial role in platelet aggregation and adhesion.
Upon platelet activation TSP is secreted and partially bound to the
plasma membrane. Since platelet function is impaired in chronic renal
failure we studied the release of TSP by uremic platelets. ACD-blood
was obtained from HD patients, pre-dialysis, and normal subjects and
platelets were activated by incubation with thrombin (0.005 and 0.1
U/liter). Activation was stopped by addition of hirudin. Plasma TSP
was determined by ELISA. TSP bound to the plasma membrane was
assessed by flow cytometry using a FITC-conjugated anti-TSP mono-
clonal antibody. Total platelet TSP was also studied by SDS-PAGE and
immunoblotting. Basal plasma TSP concentration were significantly
lower in HD patients than in normal controls (P < 0.05). In addition,
TSP release by thrombin activated platelets of HD patients was
significantly less (P < 0.05) than by normal platelets. Immunoblotting
studies of total platelet proteins revealed an increased number of TSP
immunoreactive bands with greater molecular mobility in HD patient
platelets than in the control group. In conclusion, the present data show
that TSP release is significantly impaired in platelets of HD patients,
which may play an important role in the bleeding disorders of uremia.
ACE inhibition in diabetic rats with reduced renal mass influences the
degree and the selectivity of proteinuria. H. Geiger, U. Bahner, W.
VaaBen, J. Dammrich, and A. Heidland, Departments of Nephrology
and Pathology, University of Wurzburg, and the Department of Med-
icine-Nephrology, University Erlangen-Nurn berg, Germany. Angioten-
sin converting enzyme (ACE) inhibitors may have a salubrious influ-
ence on proteinuria and the course of renal insufficiency. To test these
hypotheses, we studied the effects of enalapril (E) on 3 groups of 5/6
nephrectomy (NPX) diabetic (D) rats. D was induced with streptozo-
tocin 60 mg/kg. Thirty male rats (210 g) were randomized into 3 groups:
(I) Controls, (2) 5/6 NPX with D, (3) 5/6 NPX with DM treated with E
(50 mg/liter in drinking water from days 15 to 28. Groups (2) and (3)












Controls 0.40 118 14.1 3.6 0.7
5/6 + D 0.73 189 76.0 1.5 0.8
5/6 + D + E 0.69 l33 42.5a 1.5 0.7
a effect of E; P < 0.05)
The data show that the blood pressure-lowering effects of E also
resulted in a decrease in Up,V in 5/6th NPX rats with D. Ccr and Curea
were not affected. We used SDS gel electrophoresis to document a
change in the selectivity of proteinuna with E, and compared sclerosis
scores histologically. E improved both (P < 0.05). We conclude that E
has a salubrious influence on changes evoked by both NPX and D.
Pharmacokinetics of recombinant human erythropoietin after long-
term therapy in dialysis patients. U. Giadziwa, K. Bäumer, U. Kiotz,
K. V. Dakshinamurty, H. Mann, and H.-G. Sieberth, Department of
Internal Medicine II, Aachen, and Clinical Pharmacology, Stuttgart,
Germany. There are different opinions regarding the pharmacokinetics
of recombinant human erythropoietin (rHuEPO). The aim of our study
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was to check to what extent the pharmacokinetics of rHuEPO in
hemodialysis (HD) patients alter under long-term therapy. Ten HD
patients (age: 54 12.7 years, 24-70 years) received 150 U/kg body
weight rHuEPO i.v. after HD during the dialysis free interval. Blood
samples were collected before and 0.25, 0.5, 0.75, 1, 1.5, 2,4, 8, 12, 18,
24, and 48 hours after rHuEPO injection. The patients had been on HD
therapy for 34.6 16.3 months and had regularly received 2.000—5.000
IU after HD for 18.8 5.1 months. rHuEPO blood levels were
determined by RIA. Results: t112 = 7.7 1.5 hr; CL = 5.4 1.2m1/min;( SD) Vss = 3.6 1.0 1. t112, elimination half-life; CL: total body
clearance; Vss, steady state volume of distribution. Conclusions:
Long-term therapy did not significantly alter the pharmacokinetics of
rHuEPO (literature: t,2 = 5.2—10.6 hr). The discussed hypothesis of
"bone marrow induction" by rHuEPO could not be confirmed by our
data.
HCV antibodies in CAPD patients. U. Gladziwa, U. Schlipköter, M.
Roggendorf, H. Schmitt, K. Cholmakow, B. Lorbeer, H. Mann, and
H.-G. Sieberth, Department ofinternalMedicine II, Technical Univer-
sity ofAachen, Aachen and Max von Pettenkofer-Institute, University
ofMunich, Munich, Germany. The average prevalence of anti-HCV
(C1®) in hemodialysis (HD) patients in Germany is 10.1%, varying from
0 to 37% between the various centers. The risk of HCV infection
increases with the duration of HD. The aim of our study was to compare
the prevalence of anti-HCV in CAPD patients with that in HD-patients.
The sera of 239 patients from 8 CAPD centers was examined for
anti-HCV antibodies against a nonstructural protein (C1®) by first
generation ELISA and against a structural protein (C22) and nonstruc-
tural proteins (C33, C1®) by second generation ELISA. HCV antibodies
were found in 10 out of 239 CAPD patients (C1®; first generation
ELISA). The prevalence was 4.2% and varied from 0% to 11.1% in
different centers. Two additional patients were diagnosed with the
second generation ELISA (prevalence 5.0%). Conclusion. The average
prevalence of anti-HCV in CAPD patients is definitely lower than that
in HD patients (4.2 vs. 10.1%). Testing with the second generation
ELISA revealed no substantially higher prevalence in CAPD patients.
To explain the difference in prevalence, other transmission modes of
HCV infection, apart from blood transfusion, should be considered.
Influence of ADH on the osmoregulation of inner medullary collecting
duct (IMCD) cells of rat kidney. J,M. Grunewald, R. W. Grunewald, and
R.K.H. Kinne, Sektion Nephrologie, Abteilung Innere Medizin IV,
Universitätsklinik UIm, Max-Planck-institut für Systemphysiologie,
Dortmund, Germany. The osniolanty of the urine is regulated by ADH,
so IMCD cells are exposed to extensive changes of the extracellular
osmolarity. Therefore the influence of ADH on the intracellular con-
centrations of the organic [sorbitol (S), GPC and inositol (1)1 and
anorganic osmolytes (Na, K, Cl) and on volume regulation was inves-
tigated. The IMCD cells were isolated in 600 mOsm and incubated in
300 mOsm (hypotonic) or 900 mOsm (hypertonic) buffers. Under
hypotonic conditions after initial cell swelling a regulatory volume
decrease (RVD) occurred within 3 minutes (vs. 7 mm without ADH),
under hypertonic conditions after initial cell shrinkage regulatory vol-
ume increase (VRI) occurred within 5 minutes, whereas cells without
ADH remained shrunken at 79 2% of original volume. In the presence
of ADH the quantitative release, the time course of release (S: 10 mm;
GPC: 30 mm; I: 60 mm), and metabolism (synthesis, degradation) were
not altered. Thus ADH does not directly influence intracellular content
of organic osmolytes. VRI and altered VRD in presence of ADH were
therefore probably caused by alterations of intracellular concentrations
of Na, K, and Cl. VRD correlated to accelerated release of Na and Cl.
During VRI the uptake of Na and Cl was increased. K concentrations
remained unchanged. These results show an important role of ADH
during osmoregulation in IMCD cells. ADH seems to alter the volume
regulation by regulation of ion transport systems but not by regulation
of organic osmolytes.
Isolation and characterization of cells from rat long thin loop of Henle.
C.T, Grupp, D.l. Cohen, J.F. Silomon, M. Ragunath, R. Voisard, S.
Langhans, and H.E. Franz, Section of Nephrology, University of Ulm,
Ulm and University Children Hospital, Zurich, Switzerland. Functions
and metabolism of cells of the long thin loop of Henle (tlh) are poorly
understood up to now. For its further characterization we developed a
technique permitting the direct isolation of this cell type for the first
time. Rat papillae were enzymatically digested with collagenase and
hyaluronidase. Then cells were separated by differential centrifugation
and cleared from contaminating collecting duct cells by use of DBA-
lectin coupled beads. Staining with an antibody specific for the tlh cells
(anti-I, Dr. Roelcke, Heidelberg) revealed a purity more than 80%.
Contaminations with collecting duct cells (DBA), vasa recta (anti-
v.Willebrand factor) and interstitial cells (anti-alpha actin) were less
than 5%. tlh Cells were anti-pancytoceratin positive and anti-vimentin
negative. Na,K-ATPase activities of directly isolated tlh cells were
similar to those of papillary collecting duct (PCD) cells (3.3 0.6 vs. 3.2
0.7 M P1/mg prot . hr, NS, N = 16). However, 6-day-old primary
cultures of tlh cells and PCD cells significantly differed with respect to
prostaglandin E2 production (17.0 1.7 vs. 78.4 18.8 ng PGE2/ig
prot. hr, N = 10). The reported technique permits a relatively quick
isolation of highly purified tlh cells which makes further investigations
in this cell type possible (supported by DFG grant Gr 877/2-2).
Influence of chronic ACE inhibition on hemodynamics and proteinuria
in a chronic model of experimental immune complex glomerulonephritis
(ICGN). C. Haas, R.A.K. Stahl, M.J. Mihatsch, U. Pooth, G. Schwi-
etzer, W. Schoeppe, and F. Thaiss, University Hospital of Frankfurt,
Germany and Base!, Switzerland and Hoechst, Frankfurt, Germany.
ACE inhibitors are commonly used to treat systemic hypertension and
diabetic nephropathy. We wondered whether ACE inhibitors might
effect pathophysiology in primary immune-mediated glomerular dis-
eases. In situ ICGN was induced in uninephrectomized rats by selective
perfusion of the kidney with cationized human IgG. The ACE inhibitor
Ramipril was given in the drinking water (100 mg/liter). Treatment was
started either 2 weeks before (T = —2 weeks) or 26 weeks after (T =
+26 weeks) induction of nephritis for a total of 14 weeks. At the end of
the experiments the following parameters were examined: albuminuria
(Aur: mg/24 hr), creatinine clearance (Ccr: j.d/min/lOO g body wt) and
kidney morphology. The results demonstrate that in situ ICGN devel-
oped to a chronic model of glomerular damage. ACE inhibition did not
reduce Aur when either given before or after induction of ICGN: [ICGN
+ Ram, (T =
—2w), 70 7, (T = +24 weeks) 273 32; ICGN: (T = —2
weeks) 90 21, (T = +24 weeks) 332 45]. Additionally C. [ICGN +
Ram: (T = —2 weeks) 577 42, (T +24 weeks) 254 25; ICGN: (T
=
—2 weeks) 419 24, (T = +24 weeks) 190 32] and glomerular cross
sectional area [ICGN + Ram: (T = —2 weeks) 11 2, (T = +24 weeks)
15 4; ICGN: (T = —2 weeks) 11 2, (T = +24 weeks) 17 3mm2
x 1O] were not influenced by the ACE inhibitor. We conclude that a
chronic model of in situ ICGN can be induced in rats which is not
influenced by ACE inhibition. The data support that a therapeutic effect
of ACE inhibitors might depend on the underlying glomerular disease.
Transforming growth factor 3 (TGF$) induces bimodal effects on
mesangial cell (MC) proliferation. U. Haberstroh, G. Zahner, F. Thaiss,
W. Schoeppe, and R.A.K. Stahl, Department of Medicine, Division of
Nephrology, University of Frankfurt, Frankfurt, Germany. In experi-
mental glomerulonephritis mRNA expression of TGFI3 and PDGF/3-
receptor (PDGFBR) have been reported. TGFJ3 might play a role in
glomerular disease due to effects on matrix accumulation and on cell
growth. With respect to the possible role in cell growth, inhibitory as
well as proliferative effects depending on the cell type, have been
reported. In some cells the effects of TGFJ3 have been proposed to be
indirect due to influences particularly on the PDGF loop. To study
which role TGFI3 might have on MC growth, and whether possible
effects are interrelated with the PDGF loop, we studied the effect of the
polypeptide on cell proliferation and the mRNA expression of the
PDGFBR in rat MCs in culture. Rat MCs were utilized after multiple
passages and were cultured in DMEM with 10% FCS. Cells were
growth arrested in 0% FCS for 24 hours and then incubated with TGFI3
(1 ng/ml) over 20 minutes. Cells were kept on DMEM without serum.
Cell growth was assessed at 24 and 48 hours by cell counting or
3H-thymidine incorporation. To assess mRNA expression of PDGFBR
total RNA was extracted with phenolchloroform after cell lysis. Twenty
micrograms of total RNA was separated by electrophoresis and blots
were hybridized with a 32P labelled 2.8 kB cDNA of the human
PDGFBR. TGF/3 (1 ng/ml) induced a significant (P < 0.05) reduction of
DNA synthesis at 24 hours (723 34 cpm/5000 cells) compared to
controls (1879 164 cpm/5000 cells). At 48 hours cells treated with
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TGF/3, however, incorporated almost 5 times more 3H-thymidine (8500
279) than corresponding control cells (1419 113). mRNA expres-
sion of PDGFRB was unaffected at 24 hours; however, it was increased
at 48 hours following treatment of cells with TGF/3. These studies
demonstrate that TGF/3 in a bimodal, time dependent fashion inhibits
and stimulates mesangial cell growth in culture. A possible mechanism
might be the interrelation with the PDGF loop.
Renal ammonia production from hippurate in the rat. A. Hack!, T.
Maiyusz, M. Maiyusz, P. Wrigge, and H. Sick, Physio!ogisches Institut
der Universitãt Kiel and Bundesanstait für Milchforschung, Kiel,
Germany. Glutamine is the principle source of intratubular and intra-
cellular NH3 formation. The enzyme T-GT catalyzes tubular ammonia-
genesis (AG). This enzyme can be activated by hippurate formed out of
benzoate and glycine in the liver as well as the kidney. But the real
significance of hippurate is still in dispute. According to its chemical
structure hippurate itself could serve as substrate for renal AG either (1)
indirectly via its glycine moiety or (2) directly by forming an aclacton
which after condensation with an aldehyde spontaneously splits into
NH3, fatty acid and benzoate. Investigating this latter pathway we
measured '5NH3 production from T5Nlabelled hippurate in normal and
chronically acidotic rats: 1) in vitro using kidney slices incubated in
15N-hippurate (0.1 mM—I mM) and 2) in vivo using '5N-hippurate
infusion (2 mM). In vitro as well as in vivo '5NH3 formation was clearly
proved by mass spectrometry. In chronically acidotic rats '5NH3
production increased significantly. We previously found out that aIde-
hydes inhibit AG whereas glycerol/glyceral increases it. Together with
our current results this would be a further strong hint that hippurate
may play a direct role in renal AG via the second metabolic pathway
mentioned above.
Overexpression of PDGFI3 (c-sis), egf- (c-erB) and csf- (c-fms) receptor
in hypertrophied myocardium of SH-rats. H. Hailer, M. Behrend, J.
Fischer, A. Distier, Abt. Nephroiogie, Klinikum Steg!itz, Freie Univer-
sität Berlin, Berlin, Germany. The induction of hypertrophy of myo-
cytes in vitro is accompanied by an increased expression of protoon-
cogenes. As some of these protooncogenes are growth factor related
they may play a role in the pathogenesis of myocardial hypertrophy. To
investigate the role of protooncogenes in hypertension-induced myo-
cardial hypertrophy we studied the expression of the protooncogenes
c-sis, c-erbB, c-fms, c-fos and c-myc in intact myocardial tissue from
12-week-old spontaneously hypertensive (SH) and age-matched nor-
motensive WKY rats. In addition, myocardial tissue from 4-week-old
prehypertensive SHR was investigated. Total RNA was isolated by the
GITC-CsCl2 method and analyzed by Northern blot with 32P-labelled
specific cDNA probes. At 12 weeks of age both blood pressure and
heart weight were significantly higher in SHR (N = 8, P < 0.05) as
compared to the normotensive animals. mRA levels showed an approx-
imate 3- to 4-fold increase for c-sis, a 4-fold increase for c-erbB and a
5-fold increase in c-fms at 12 weeks in SHR, whereas the expression of
c-fos and c-myc was not different. At 4 weeks no increase in protoon-
cogen expression was observed in the SHR. It is concluded that
hypertension-induced myocardial hypertrophy is accompanied by a
sustained expression of c-sis, c-erbB and c-sis but not of the early
response genes c-fos and c-myc. The increased expression of peptide
growth factors and growth factor receptors indicate paracrine mecha-
nisms in myocardial hypertrophy.
Angiotensin II (Ang II) and platelet-derived growth factor (PDGF)
induce expression of PKC-f3 and PKC-a in vascular smooth muscle cells.
H. Hailer, C. Lindschau, J. Fischer, and A. Distier, Abt. Nephrologie,
Klinikum Steglitz, Freie fjniversitat Berlin, Berlin, Germany. Activa-
tion of protein kinase C (PKC) by growth factors plays an important
role in cellular growth and differentiation. PKC exists as a family of
different isoforms derived from distinct genes but little is known about
the specific roles of the isozymes in cell growth. In the present study we
investigated, therefore, PKC activity and the expression of the PKC
isoforms a, /3 and y in vascular smooth muscle cells (VSMC) from rat
aorta after exposure to PDGF (100 ng/ml) and angiotensin II (Ang II)
(l0 M). PKC activity was measured by histone phosphorylation. PKC
isoforms were assessed by immunoblot using polyclonal antibodies for
PKC isoforms a, /3 and y. Exposure of the cells to PDGF and Ang II
induced a rapid translocation of PKC from the cytosol to the cell
membrane within minutes. Longer exposure of the VSMC to Ang II and
PDGF led to a 3- to 6-fold increase in total PKC activity after 2 and 6
hrs. Immunoblot analysis showed an increased expression of PKC-/3
and -', while PKC-a was unaltered. Our results show that growth
factors (PDGF) and trophic hormones (Ang II) rapidly activate PKC in
VSMC, while a prolonged exposure of VSMC to PDGF and Ang II
induces an increased expression of PKC-/3 and, to a lesser extent, of
PKC-y. The time course of the increased PKC expression suggests a
translational effect of the growth factors. increased expression of
PKC-/3 and -y seems to be important for the long-term effects of growth
factors.
Decompensated benign nephrosclerosis and focal sclerosing glomerulo-
nephritis. Diagnosis and differential diagnosis. M. Hanatani, M. Wehr-
mann, S. Mackensen-Haen, and A. Bohie, Institute of Pathology,
University of Tubingen, Tubingen, Germany. We report on focal
sclerosing glomerulonephritis (FSGN) as defined to decompensated
benign nephrosclerosis (DBN), because in the literature DBN is ap-
pointed to FSGN and therefore is not mentioned. For this study renal
biopsies from 186 cases of FSGN and from 101 cases of DBN were
available. The following results could be obtained: (I.) FSGN and DBN
show focal and segmental glomerular lesions in the sense of hyalinosis
and sclerosis. These changes which correspond to lesions seen in
hyperperfusion, in DBN predominantly are localized in the hilar region
of the glomeruli, in FSGN however in the periphery of the glomerular
capillaries. They are more often subendothelially deposited in FSGN
than in DBN, complicated by fat droplets and by endothelial foam cells.
(2.) Vascular lesions, i.e. arteriolosclerosis, are found inobligatory in
FSGN, in DBN the vascular changes are characteristic. (3.) Both
diseases show obligatory in DBN and inobligatory in FSGN interstitial
fibrosis of the renal cortex. (4.) Usually in FSGN the patients are
normotensive or slightly hypertensive. In DBN malignant hypertension
is regularly observed. (5.) In FSGN with partly nonsystematic therapy
(steroids, steroids + cytostatica) in 70% the nephrotic syndrome (NS) is
found. In DBN mostly rather considerable proteinuria is observed but
never a NS. (6.) FSGN is found as often in man as in woman (m:w =
1.3:1), DBN is found predominantly in man (m:w = 3.4:1). DBN is its
own disease which can be defined to FSGN using morphological and
clinical data.
Nephrotoxic effect of short-term concomitant administration of cyclos-
porin A (CsA) and acyclovir (AC) in rats. J. Hannemann, W. Wunderle,
and K. Baumann, Department of Cell Phyisology, University of Ham-
burg, Hamburg, Germany. Cyclosporin A (C5A), an immunosuppres-
sant, and acyclovir (Ac), an antiviral drug, may cause renal functional
impairment. CsA induced immunosuppression increases the rate of
viral infections, such as shingles. Therefore the effect of short-term
co-administration of CsA and Ac on renal function in male Wistar rats
was investigated. Animals were treated with CsA (20 mg/kg body wt,
s.c., once daily for 8 days), Ac (15 mg/kg body wt, s.c., three times
daily for the last 5 days) or a combination of CsA and Ac. Plasma levels
of CsA and Ac after a single dose of each were determined. Urines were
monitored for volume and osmolality, total protein and N-acetyl-/3-D-
glucosaminidase (/3-NAG). Concentrations of plasma creatinine and
blood urea nitrogen (BUN) were determined (day 9), kidneys isolated,
weighed and monitored for transport of weak organic acids and bases,
CsA induced a decrease in body and kidney weight, in urine osmolality
and in excretion of total protein. Plasma creatinine and BUN were
increased by CsA. Ac did not induce significant changes. In comparison
to CsA values, urine volumes and /3-NAG excretions were enhanced by
the concomitant administration of CsA and Ac. Short-term antiviral
therapy with Ac in CsA treated patients might involve a slight increased
nephrotoxic risk. Long-term effects should be investigated in further
studies.
Effect of ACE inhibition on filtration properties of glomerular basement
membrane in type II diabetic patients with nephropathy. C. Hasslacher,
A. Bostedt, E. Werle, and R. Ziegler, Medicine University Clinic,
Department of Endocrinology and Metabolism, Heidelberg, Germany.
Decrease of proteinuria observed under treatment with ACE inhibitors
is usually explained by the hemodynamic effects of these drugs. To
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investigate (nonhemodynamic) effects of ACE inhibition on the filtra-
tion properties of glomerular basement membrane we studied clear-
ances of albumin and IgG (Einstein Stokes radius 36 and 55 A,
respiratory) in 12 type II diabetics with micro- or macroalbuminuria
before and after a 2 and 6 month treatment period with the ACE
inhibitor lisinopril (US). Parameters measured were: GFR (mum),
fractional clearances of albumin (CAIb) and IgG (C1,-), selectivity index(SI; = CIgG/CAb), blood pressure, HbAI. Compared with results of
pretreatment period, GFR and HbA1 did not change during LIS
therapy. After 2 months of therapy blood pressure, CA[b and C1
significantly decreased, SI did not change. During the next treatment
period (2 to 6 month), CAIb and C1g0 further decreased whereas blood
pressure remained unchanged. SI changed from 0.36 to 0.50. Conclu-
sion: Due to long-term therapy with LIS, transglomerular passage of
small and large molecules was lowered irrespective of the hemody-
namic effect of ACE inhibition. These results indicate that LIS im-
proved the filtration properties of basement membrane in diabetics with
nephropathy.
Cloning of cDNAs encoding a rabbit renal Na/H exchanger. F.
Hildebrandt, J,H. Pizzonia, R.R. Reilly, N.A. Reboucas, C. Sardet, J.
Pouyssegur, C. W. Slayman, P.S. Aronson, and P. Igarashi, Depart-
ments of Internal Medicine and Human Genetics, Yale University
School of Medicine, New Haven, Connecticut, USA, and CNRS,
Universite de Nice, Nice, France. Na/H exchangers are plasma
membrane proteins that are present in most vertebrate cells and are
responsible for regulation of intracellular pH, control of cell volume,
and response to mitogens. In mammalian kidney, Na7H exchangers
also mediate transepithelial flux of NaCI and NaHCO3. Recently a
cDNA encoding a human growth factor activatable Na/H exchanger
of unknown tissue origin was isolated. Northern blot analysis revealed
that a homologous 4.7 kb transcript was expressed in rabbit kidney.
Using PCR and cDNA library screening we cloned overlapping 2.5 kb,
1.4 kb, and 1.8 kb cDNAs that together contained the entire coding
region and portions of the non-coding regions of a rabbit renal Na/H
exchanger transcript. The composite nucleotide sequence of the rabbit
renal NaIH exchanger cDNA was 3372 bp and was highly similar to
the human sequence (75%, 92%, and 81% identity in the 5' untranslated,
coding, and 3' untranslated regions, respectively). The single long open
reading frame was predicted to encode a protein of 816 amino acids
which was also highly similar to the human sequence in predicted
primary and secondary structure (95% amino acid identity). Northern
blot analysis revealed that the transcript was expressed in many rabbit
tissues consistent with the distribution of an NAH-l isoform.
Interstitial nephritis with reversible renal failure due to a copper-
containing intrauterine device (IUCD). B. Hocher, F. Keller, and P.
Gross, Department of Medicine, Klinikum Ste glitz, Berlin, Germany. A
41-year-old woman was admitted to the hospital because of renal failure
requiring hemodialysis treatment. She had a personal history of nickel
and chrome hypersensitivity; no medications were reported. She had
been wearing a copper-containing intrauterine device for the past 18
months. Allergy to copper was proven with an in vitro lymphocyte-
stimulating test and a cutaneous patch test. Hemolysis, Wilson's
disease or acute tubular necrosis could be excluded. Renal biopsy
revealed active chronic interstitial nephritis with infiltration by lympho-
cytes and eosinophilic granulocytes but without glomerular involve-
ment, vessels were normal. By immunohistochemistry no IgG, IgA,
1gM or complement deposits were seen. Steroid administration had
only limited improvement. However, renal function normalized over
several month after removal of the copper-containing intrauterine
device (IUCD). Contact dermatitis and urticaria to a copper-IUCD are
well-known but rare T cell related side-effects in women with copper
allergy. To our knowledge, this is the first case reported with copper
allergy and renal failure. We therefore propose that copper-IUCD-
wearing women with a hypersensitivity to copper may be at risk for
interstitial nephritis.
Percutaneous biopsy of native and allograft kidneys using a semiauto-
mated device: Histomorphology and complications. M. Hollenbeck, D.
Bach, F.W. Kemmer, U. Helmchen, and B. Grabensee, Department of
Nephrology, Heinrich-Heine University, Düsseldorf and Department of
Pathology, University-Hospital Eppendorf, Hamburg, Germany. Renal
biopsy is necessary for diagnosis and follow-up of many diseases with
renal impairment. This procedure, however, may result in significant
complications and the risk is to be considered carefully in any individual
case. We report 75 kidney biopsies with an semiautomatic firing device
and a small caliber needle. All complications are reported. With
ultrasonic guidance percutaneous biopsy was performed in 37 native
and 38 allograft kidneys using the semiautomatic firing "BIOTY"
device (Radioplast AB, tjppsala, Sweden) with a 1.2 mm caliber needle
(Bard Urological Division, Covington). After 24 hours of rest, hemato-
crit, urinalysis and ultrasonic scan was repeated. As a control group we
analyzed the number of glomeruli in 262 kidney biopsies which were







Bard needle 75 6.53 4.24 1.21 0.40 cm 2 (2.7%)
Tru-cut needle 262 10.75 7.20 1.44 0.64 cm 13 (5.0%)
Sign.-Niveau P < 0.0005 P < 0.005 P < 0.001
With the Bard needle only two cases of macroscopic hematuria without
requirement of blood transfusion and two very small perirenal hemato-
mas were observed. We found that native and allograft kidney biopsy
with this technique provides an adequate specimen without severe
complications. With the spring-loaded device the performance of bi-
opsy is done in a fraction of a second. Every pass produces a specimen
in good morphologic condition, which in most cases is sufficient for a
proper histologic diagnosis.
Regulation of Na coupled amino acid transport in proximal tubule
cells by transmembrane potential (Vm). J. Hoyer, A. Distler, H. Go-
ge/em, University Clinic Steglitz, Berlin, and Max-Planck-Institut für
Biophysik, Frankfurt, Germany. The transport mechanism of the Na-
L-alanine cotransport and its regulation by Vm was investigated with
the whole-cell recording mode of the patchclamp technique in single
proximal tubule cells (Si segment) from New Zealand white rabbit
kidney. The cotransport current (I) showed to be stereospecific, Nat-
dependent, independent of extracellular pH, and increased with nega-
tive Vm. Maximal transport rate (lmx,j, measured at —60 mV, Na
concentration extracellularly (cx) = 140 m and intracellularly (i,,) = 0
mM, in absence of C1 (cyclamate as anion), was 0.98 pA/pF at a Km
of 6.7 m alanine (Ala) being in the same order of magnitude as the
transport rate required for alanine reabsorption in proximal convoluted
tubule. Kinetic data analysis revealed the following transport mecha-
nism properties: cotransport occurs simultaneously and with coupling
stoichiometry of I Na: 1 Ala. Im,,, was Vm-dependent (0.54 pA/pF at
0 mY vs. 0.98 pA at —60 mV) as well as Km for Na (29 m at 0 mV
vs. 11 mM at —60 mV), whereas Km for Ala was unaffected by V,,, (7.9
mM at 0 mV vs. 6.7 m at —60 my). This suggests a Vm-dependent
translocation step and a Vm-dependent Na-binding to the cotrans-
porter. Measurements in the presence of Cl ([ClIjn_ex 140 mM)
yielded a 31% higher transport rate, measured at Alaj = 20m. This
suggests either a blocking effect of cyclamate or a stimulating role of
C1. In conclusion, Na-L-alanine cotransport is regulated by Vm and
possibly also by anions. Vm affects the translocation step of the loaded
carrier and the Nat-binding to the carrier molecule.
Effect of nifedipine on glomerular capillaries in a model of spontaneous
glomerulosclerosis (GS). Tomasz Irzyniec, Gerhard Mall, Eberhard Ritz
Department Pathology and Internal Medicine, Ruperto Carola Univer-
sity Heidelberg, Heidelberg, Germany. In SHRsp nifedipine effectively
lowers blood pressure and in parallel reduces development of GS. We
had also demonstrated (Mall et al., 1990) increased capillary density in
the myocardium of SHRsp chronically treated with nifedipine. In the
present study, glomerular vascular architecture was examined by
stereological methods in male SHRsp age 6 months treated chronically
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(3 months) with nifedipine (27 mg/kg/day in food pellets) or with the
sympathicolytic agent Moxonidine (8 mg/kg/day).
SHR- SHR-
WKY SHR-co nifedipine Moxonidine(N = 10) (N = 9) (N = 9) (N = 9)
116 16 193 38.6 144 21.4" 144 13.5
2.64 0.09 4.06 0.97 3.84 3.36 0.12
6.9 2.2 93.0 68.0 27.2 12.9" 18.2 9.8
106 17.7 123 28.9 139 l8.8a 113 18.7
80.9 12.1 69.3 14.3 94.6 l5.7a 78.5 12.8
31.3 5.8 23.5 5.55 34.8 70a,b 28.6 4.54
429 56.3 452 120 553 907b 449 72.7
2.07 0.17 2.50 0.38 2.15 0.31 2.15 0.11
In chronically nifedipine-treated SHRsp, attenuation of GS was paral-
leled by high filtration surface and high capillary length. This argues for
an effect of chronic nifedipine treatment on glomerular capillary archi-
tecture. These changes were not seen with blood pressure lowering
using a sympathicolytic agent.
Stimulation of beta2-microglobulin (jJ2m) synthesis in human lympho-
cytes by Cuprophan dialyzer membranes. B. Jahn, M. Betz, R. Dep-
pisch, G.M. Hänsch, E. Ritz, Inst it Ut für immunologie and Med. Klinik
der Universitat Heidelberg, Fa. Gambro Dialysatoren GmbH, Hechin-
gen, Germany. Hemodialysis-related amyloidosis is attributed to high
levels of circulating 132 in long-term dialysis patients. To test whether
contact of peripheral blood cells (PBL) with the dialyzer membrane
would lead to enhanced synthesis of /32m, PBL of healthy donors were
cultivated in the presence of Cuprophan membrane. After 24 hours the
/32m specific mRNA was increased, after 36 hours an increase of surface
expression could be detected, and after 72 hours an increment in f32m
release into culture supernatants was seen. To investigate whether
stimulation of f32m synthesis also occurs during dialysis, PBL of
short-term dialysis patients were isolated before and after dialysis
employing Cuprophan membranes, and cultured for 24 hours. In a part
of the patients an increase in /32m specific mRNA was seen after
dialysis. As has been shown in the in vitro experiments, a 2 to 4 hour
contact of PBL with the Cuprophan membrane was sufficient to
stimulate $2m synthesis.
The impact of metabolic control on the excretion of tubular markers in
patients with type 1 diabetes mellitus. E. Jungmann, A. Galette, B.
Hopfenmuller, J. Scherberich, K.-H. Usadel, Center of Internal Med-
icine, Johann Wolfgang Goethe-University, Frankfurt am Main, Ger-
many. There is considerable controversy regarding the question of
whether or how tubular alterations, potentially determined by the
quality of metabolic control, may contribute to the pathogenesis of
diabetic nephropathy in patients with type 1 diabetes mellitus. There-
fore, we decided to examine the urinary excretion of /3NAG, angioten-
sinase A (ATA), alkaline phosphatase (AP), gamma-glutamyltrans-
ferase (GGT) and aminopeptidase M (AAP) as well as urinary albumin
excretion (UAE), the clearances of creatinine (Car) and sodium (CNa*)
and clinical and hormonal characteristics in 13 patients with good
metabolic control (age, 29 2 years, HbA, < 8.5%) and 9 patients with
insufficient metabolic control (age, 34 2 years, HbA, > 8.5%). Ten
healthy volunteers (age, 29 2 years) acted as controls. Patients with
HbA,> 8.5% differed from controls or patients with HbAI < 8.5% (P <
0.05) in longer diabetes duration, increased prevalence of retinopathy or
neuropathy, decreased plasma renin activity, increased somatomedin C
levels in plasma, as well as an increased urinary cGMP excretion,
although human atrial natriuretic peptide (hAMP) levels in plasma were
within normal range and not different, Blood pressure and clear Na
were also not different. Whereas clear crea was normal and did not
differ from values in controls or patients with HbA, < 8.5%, UAE was
increased (P < 0.05). Likewise increased were: PNAG, AAP, AP (P <
0.05), but not GGT or ATA. Patients with HbA, < 8.5% differed from
controls only in elevated /3NAG excretion (P < 0.05). Thus, insufficient
metabolic control in type I diabetes mellitus is associated not only with
more prevalent diabetes sequelae, including signs of progressive dia-
betic glomerulopathy, but also with the evidence of tubular alterations.
There may be differences in the sensitivity of the responsiveness of the
particular brush border enzymes. Moreover, the prominent excretion
patterns of 13NAG and cGMP (unexplained by differences in hAMP
levels) deserve future study.
Urine excretion of immunoreactive 11-keto-thromboxane 132 (i-ilk-
TXB2) in diabetics with intensified insulin therapy (I.I.T). A. Kahi, A.
.Järres, D. Kampf, T. Schirop, C.v. Wissmann, K. Petersen, G.M.
GahI, and R. Djurup, Department of Internal Medicine (Nephrology)
and (Intensive Care) UKRV-Charloztenburg, Berlin, Germany, and
Novo Nordish, Bagsvaerd, Danmark. It is suggested that in patients
with diabetes mellitus an increased systemic formation of thromboxane
A2 (TXA2) ensues due to thrombocyte hyperreactivity. Furthermore, a
connection between renal TXA2 synthesis and albuminuna could be
demonstrated in animal tests. Therefore, we examined the excretion of
i-I lk-TBX2—a stable metabolite of TXA2—in the 12-hr night urine of
112 diabetics (46 f/66 m, age 20 to 73 years (range 41.5), diabetes
duration (DD) from Ito 56 years (range 12) with I.I.T (pump or pen) and
normal serum creatinine. Determination of i-I lk-TXB2 was carried out
by ELISA, determination of albumin by RIA. For glomerular filtration
rate assessment the calculated endogenous creatinine clearance was
used. The mean excretion of i-Il k-TXB2 was found at 1.7 (0.3—16.6)
sg/min (range (mm-max)) and was independent of age, sex and DD.
Twenty-two of 112 patients showed albumin excretion (AER) of more
than 18 sgJmin. They showed a significantly increased excretion of
i-I lk-TBX2 compared with patients with normal AER [2.2 (0.4—6.4) vs.
1.5 (0.3—16.6) tg/min, P < 0.04]. Increased i-l lk-TXB2 excretion could
also be found in patients with glomerular hyperfiltration. The increased
excretion of i-I lk-TXB2 in patients with microalbuminuria and/or
hyperfiltration is another indication for thromboxane synthesis in the
early phase of diabetic nephropathy. Thus, the detection of i-I lk-TXB2
in urine could be an interesting parameter for the clinical monitoring of
patients with diabetes mellitus.
Effect of parathyroid hormone on protein kinase C activity in primary
rat osteoblast-like cells. J. Klein, P. Fanti, H.-E. Franz, and H.H.
Malluche, Division of Nephrology, University of Ulm, Ulm, Germany
and Division of Nephrology, University of Kentucky, Lexington, Ken-
tucky, USA. The calcium and phospholipid-dependent protein kinase C
(PKC) system appears to play an important role in mediating hormonal
effects in various tissues. We investigated the effects of phorbol
12-myristate 13-acetate (PMA), and of parathyroid hormone (PTH) on
PKC activity in primary osteoblast-like cells derived from neonatal rat
calvariae. PKC activity was assayed by measuring the phosphatidyl-
serine/diolein-dependent transfer of 32Pi from [y-32PIATP into histone
111-S. After 2, 5, 10, and 20 mm of incubation with 100 nM PMA
membrane-associated PKC activity increased to 139%, 183%, 169%,
and 170% of the control value, respectively, whereas cytosolic PKC
activity decreased to 46%, 19%, 9%, and 7% of the control value,
respectively. Such a typical PKC translocation pattern was not ob-
served in response to PTH. After 2, 5, and 10 mm of incubation with 70
flM PTH (1-34 bPTH) membrane-associated PKC activity also increased
to 146%, 178%, and 132% of the control value, respectively; however
cytosolic PKC activity initial increased (after 2 mm) to 128% and then
decreased to 90%, and 81% of the control value, respectively. The data
demonstrate the existence of a phorbol ester-activated PKC system in
primary osteoblast-like cells, and suggest that 1-34 bPTH is able to
activate PKC in this system.
Influence of reduced cyclosporine dose on the long-term course in renal
transplant recipients with assumed cyclosporine toxicity. V. Kliem, H.
Repp, and U. Frei, Departments of Nephrology and Transplant Sur-



















a p0.05 vs. WKY; b P 0.05 vs. SHR controls
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immunosuppressive therapy from cyclosporine (Cs) and prednisolone
(P) on triple drug therapy using azathioprine (Aza) and simultaneously
reducing the Cs dose may be successful in renal transplant recipients
(RTR) with clinical signs of Cs toxicity. This retrospective study
included all RTR (11 women, 9 men), who from 11/87 to 5/89 were
converted on triple drug therapy because of slow progression of renal
failure at clinically assumed Cs toxicity. The Aza dose was 1.66 0.37
mg/kg/day, the Cs trough level amounted to ——70 ng/ml. Particularly,
changes of liver and renal function, blood count, and lipid status were
investigated using Student's t-test for paired cases. Conversion oc-
curred 27.6 months (6—52) after transplantation (Tx). Patient average
age was 36.4 years (23—54), follow-up after conversion 31.7 months
(21—42). Cs dose could be reduced by 37% (22—54), Cs trough level
mounted to 74 39 ng/ml. During and after the conversion rejection did
not occur. Liver function was not influenced, bone marrow depression
was not observed. Lipid status did not significantly change. Serum
creatinine (zmol/liter) in stable Tx-function was 157 46, before
conversion 241 55, that is, 65% (46—83) of stable Tx function (P <
0.001). One, 2 rsp. 3 years later graft function again reached 80%
(53—110), 80% (62—1 10) rsp. 81% (66—97) of initial function (Se. 198 43,
N = 19; 193 54,N = 17; rsp. 225 27, N = 9;concerning Tx function
at conversion all P < 0.001). In RTR with clinical signs of Cs
nephrotoxicity, a further progression of renal failure can be prevented
by converting patients to triple drug therapy and reducing the Cs dose.
Moreover, in the long run an evident amelioration of renal graft function
can be reached.
Cyclosporine metabolism in renal transplant recipients after conversion
to triple drug therapy because of signs of cyclosporine toxicity. V. Kliem,
J. Bleck, U. Christians, H. Repp, K.F. Sewing, and U. Frei, Depart-
ments of Medicine, Pharmacology and Surgery, Medical School Han-
foyer, Hannover, Germany. Immunosuppressive therapy of renal
transplant recipients (RTR) with azathioprine (Aza), cyclosporine (Cs),
and prednisolone (P) may be a successful regime in RTR with clinical
signs of Cs toxicity, as, compared to a therapy with Cs/P, Cs dose can
be reduced. It was the aim of the present investigation to study
metabolic pattern of Cs and its metabolites (CsM) in AzaJCs/P rsp. Cs/P
treated RTR (trough level —-100 rsp. 130 ng/ml). Nineteen patients,
converted from Cs/P to triple drug therapy (Aza: 1.74 0.37 mg/kg/day,
Cs: 4.0 1.2 mg/kg/day, P: 7.5 mg/day) because of clinical signs of Cs
toxicity, were compared with 21 patients treated with Cs/P without
signs of Cs toxicity (Cs: 4.3 1.5 mg/kg/day, P: 7.5 mg/day) by
measuring Cs and 17 CsM in blood (trough level) and 24 hour urine
using HPLC. Both groups were comparable in age, sex, and time after
transplantation. There was no difference in liver function, but Scr was
significantly elevated in the Aza/Cs/P-group (228 99 vs. 168 77
ug/mI, P < 0.013). Although both groups had significantly different Cs
trough level in blood (AzaJCs/P: 99 10 vs. 128 6 ng/ml, P < 0.007)
the required Cs dose was nearly identical. Both groups differed in
metabolic pattern in the trough level for CsM AMI (Aza/Cs/P: 121 15
vs. Cs/P: 191 13 ng/ml, P < 0.04), AM9 (Aza/Cs/P: 48 7 vs. Cs/P:
69 7 ng/ml, P < 0.01) and AMIc (Aza/Cs/P: 30 8 vs. Cs/P: 9 5
ng/ml, P < 0.01). A subpopulation of Cs treated RTR was identified, in
which—as a result of a different cytochrome P 450 dependent Cs
metabolism—Cs toxicity cannot be avoided, if only the Cs trough level
is considered.
Diversity of the surface electric charge on red blood cells in different
types of glomerulonephritis. M. Klinger, S. Kramarz, W. Kopec, and Z.
Szewczyk, Department of Nephrology, Medical Academy, Wrocaw,
Poland. There is some evidence that the predisposition to the particular
type of glomerulonephritis (GN) is connected with a specific features of
the glomerular structures, especially with the glomerular polyanion
charge. The controversial data suggest that the negative charge on the
surface of red blood cells (RBC) may reflect the charge on the
glomerular capillaries. Therefore, in the present study the charge on
RBC was measured by means of alcian blue binding in five groups: a
control group comprising 36 healthy persons, 17 patients with mesangial
GN, 15 patients with mesangiocapillary GN, 14 patients with membra-
nous GN, and 7 subjects with minimal change GN. The patients were
tested at the stage of normal renal function. The results were analyzed
separately for the patients with nephrotic syndrome and for those in
remission. In patients with mesangial and minimal change GN, tested in
remission, the charge on RBC was not different from normals, whereas
it lowered significantly in the subjects with nephrotic proteinuria. In the
groups of mesangiocapillary and membranous GN the fall of the charge
on RBC was observed, irrespective of their clinical state (remission or
nephrotic syndrome). Conclusions: (1.) In mesangial and in minimal
change GN the decrease of the charge on RBC occurs only in the
presence of nephrotic proteinuria. (2.) In membranous and mesangio-
capillary GN the reduced charge on RBC appears irrespective of the
proteinuria and is probably the pre-morbid feature, perhaps reflecting
the characteristic of glomerular capillary wall predisposing to the
development of this type of GN.
Incidence of coronary artery disease (CAD) in diabetics with end-stage
renal disease (ESRD). M. Koch, F. W. Kemmer, T. Koeser, W. Motz,
BE. Strauer, B. Grabensee, Departments of Nephrology and Cardiol-
ogy, University of Duesseldorf, Duesseldorf, Germany. Diabetics with
ESRD have a higher risk of cardiovascular mortality than their non-
diabetic counterparts. Coronary artery disease is the main cause of
death. We are performing coronary angiography in all diabetics with
ESRD who are supposed to be eligible for kidney transplantation. We
evaluated coronary angiography results in 69 diabetics (54 type I, 15
type II; 43 men, 26 women). At the beginning of renal replacement
therapy, mean age was 41 (23—65) years, mean duration of diabetes until
ESRD was 21(2-41) years, the mean serum cholesterol 255 70 mg/dl,
triglyceride 223 + 117 mg/dl, HbAlc 7.7 1.6%. Sixty-four diabetics
(93%) had hypertension, 42 diabetics (78%) had diffuse sclerosis of at
least one coronary artery, 26 of 42 diabetics (62%) had a coronary artery
stenosis > 70%, 6 of 42 patients (14%) present coronary artery
occlusion. Seventeen of 42 (40%) diabetics were symptomatic with
angina pectoris, 25 of 42 (60%) had no clinical symptoms. Before
undergoing renal transplantation in 9 of 42 diabetics (21%) a dilatation











































Conclusion. These data suggest that in diabetics with ESRD the high
incidence of CAD is closely associated with a low incidence of angina
pectoris. Therefore, we strongly recommend the performance of coro-
nary angiography in diabetics on CAPD or hemodialysis prior to renal
transplantation.
Ten years of erythrocyte morphology. H. KOhler and E. Wandel, I.
Medizinische Klinik, University of Mainz, Mainz, Germany. In 1979
Birch and Fairley first described "dysmorphic" erythrocytes as a sign
of glomerular bleeding. However, in clinical practice detection of
"dysmorphic" erythrocytes proved to be of limited value: (1.) There is
considerable overlap between the presence of "dysmorphic" erythro-
cytes, that is, glomerular hematuna (gh) and nonglomerular hematuria
(ngh). (2.) The percentage of dysmorphic red cells which should be
taken to indicate glomerular bleeding varies greatly in the literature
between 10 and 80%. The main reasons for these differences are the
lacking definition of what is "dysmorphic" and the different pathophys-
iological meaning of the various erythrocytic deformities. Midstream
urine samples (second morning urine) of 35 patients with hematuria (>8
RBC/d) and of 33 healthy subjects were examined by phase contrast
microscopy within two hours after voiding. The various forms of red
cells in the urine were described following a hematological classifica-
tion. Most of the "dysmorphic" erythrocytes (echinocytes, anulocytes,
ghosts, schizocytes, stomatocytes, codocytes, knizocytes) were seen in
gh and in ngh, as well with the exception of acanthocytes, a ring form
with vesicle-shaped protrusions, which proved to be characteristic for
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glomerular bleeding (specificity 98%). Exposure of RBC to solutions
with various osmolaljtjes (145—1600 mOsm/liter), pH (3—11) or employ-
ing the coverslip induced most types of dysmorphic erythrocytes but
not acanthocytes. Therefore, the clinical workup should focus on
acanthocytes, and it should omit the great variety of unspecific dys-
morphic red cells. Acanthocyturia proved to be a sign of "glomerular"
bleeding, whereas red blood cell casts indicate "renal" bleeding. No
correlation of diagnostic value was found between the pattern of
"dysmorphic" erythrocytes and the pattern of glomerular histology. As
in healthy subjects no acanthocyturia was seen, and the presence of
acanthocyturia seems to be suitable to detect glomerular erythrocyturia
even in patients with low to normal levels of hematuria.
Plasma parathyroid hormone and erythropoietin levels in patients with
noninflammatory acute renal failure. F. Kokot, A. Wiecel, and W.
Grzeszczak, Department of Nephrology, Silesian School of Medicine,
Katowice, Poland. PTH is incriminated as an uremic toxin involved in
the pathogenesis of anemia in chronic renal failure. This fact was the
background of our present studies performed in 14 patients with
noninfiammatory acute renal failure (NARF). Plasma levels of erythro-
poietin (EPO) and parathyroid hormone (PTH) were estimated at the
anuric-oliguric and polyuric phase of NARF. At the anuric-oliguric
phase plasma EPO levels were predominantly normal, although inap-
propriately low to the degree of anemia. In 50% of patients with NARF
episodic short-term increases of plasma EPO levels were noticed which
were not caused by worsening of anemia. At the polyuric phase plasma
EPO concentrations were in the normal range (17.9 + 3.3 mU/mi) in
spite of the same degree of anemia as at the anuric-oliguric phase.
Plasma PTH levels were significantly elevated during the anuric-oliguric
phase (1.13 0.1 ng/ml) with a tendency to decline at the polyuric
phase (0.87 0.2 ng/ml). No correlation was found between plasma
EPO and PTH concentrations. Results presented in this study suggest
the presence of relative EPO deficiency both during the anuric-oliguric
and polyuric phases of NARF. As plasma PTH levels were not
significantly correlated with serum EPO concentrations, its role in the
pathogenesis of suppressed EPO levels seems unproven. Results pre-
sented in this study suggest deterioration of the physiological feedback
between EPO secretion and the magnitude of erythropoiesis in NARF.
Sport as rehabilitation for dialysis patients in retrospect. R. Krause,
F.A. Muthny, R. Kielstein, A. Daul, and G. Asmus, Krankenhaus
Moabit & St. Joseph, Berlin; Psychological Institute, University
Freiburg, Freiburg Medical Akadademy, Magdeburg; Medical Univer-
sitats-Klinik Essen, Essen, Germany. After the successful use of sport
as rehabilitation for coronary heart disease patients, it is increasingly
being used for dialysis patients. This study retrospectively examines
(I.) what expectations the participants had, (2.) what sports, if any, they
had previously undertaken, (3.) whether the participants were satisfied
with their treatment at that time and subsequently their quality of life.
Forty-nine questionnaires from 3 dialysis sports groups were evaluated:
53% women, 47% men aged 35—65 years. Reasons for participation
were: 47% to stay fit; 55% to improve their performance. A total of 43%
felt their abilities to cope with daily life had improved; 40% generally
felt better; 28% felt their lack of mobility during dialysis was compen-
sated. Only 35% of the sports-group participants were dissatisfied with
their physical performance and only 14% with their mental perfor-
mance. With dialysis patients, physical capacity is reduced in end-stage
renal failure and complicated by dialysis treatment. Rehabilitation
sports-groups specifically designed to meet the needs of chronic renal
insufficiency patients and dialysis patients can be of assistance. As their
performance improved, these patients felt more contented. They began
to take more interest in everyday activities. Self-awareness, both
physically and mentally, and group dynamics increase self-confidence
and self-esteem and, through the transfer-effect, lead to a better quality
of life.
Analysis of cell migration between the graft and the host after rat
kidney transplantation. M. Krzymañski, K. Ulrichs, A. Oko, A.-M.
Waaga, A. Deja, and W. Miiller-Ruchholtz, Department of Nephrol-
ogy, Med. A cad. Poznañ, Poland, and Department of Immunology,
University of Kiel, Germany. In 18 rats kidney transplantation (KTx)
was performed according to Lee's technique. DA and LEW rats were
used as donors and recipients. Grafts were perfused with PBS or with
anti-MHC class II MoAb (29A1-Kiel) and incubated 60 mm in 4°C. For
the detection of cell migration grafts were explanted 4, 8, 24, 48 and 72
hours postoperatively. Spleen and mesenteric lymph nodes were re-
moved for immunohistology. Results: (a) After KTx migration of MHC
class H positive cells from the graft to the recipient's spleen was
observed with subsequent reduction of their number in the graft. (b)
Perfusion of kidneys with anti-MHC class II MoAb resulted in a similar
reduction of cell number in the graft, but the number of donor cells in
the spleen was smaller than after KTx of PBS perfused grafts. (c) Two
days after KTx migration of recipient cells into the graft was observed.
(d) Accumulation of class Il-positive donor cells was found in perivas-
cular spaces. These cells were surrounded by recipient's class II cells as
well as Ox 19+ lymphocytes. (e) Survival of MoAb-perfused grafts was
significantly longer than of PBS perfused grafts (9.6 0.8 vs. 7.7 0.5
days). (1) Perfusion of the graft with MoAb and treatment of the
recipient with a reduced dose of 15-deoxyspergualin (0.2 mg/kg i.p.)
prolonged graft survival to 146 17 days. It may be concluded that
perfusion of the graft reduces its immunogenicity. This pretreatment
obviously prolongs graft survival with reduced doses of immunosup-
pressive drugs, which otherwise remain effectively low.
Origin of renal cysts: An immunohistological study. R. Kuch, C.
Albers, M, Schneider, H. Panitz, and J.E. Scherberich; Abt. Nephrol-
ogie, Zentr. Pathologie, Universitats Klinik Frankfurt/Main, Main,
Germany. To elucidate histogenetic aspects of renal cysts, paraffin-
embedded kidney sections from 25 patients (pts) with acquired cystic
disease (ARCD), 13 pts with dominant (DPKD) or recessive polycystic
kidney disease (RPKD), and of multicystic dysplasia (MCD) were
studied using a polyclonal antibody, specific for proximal brush border
membrane glycoprotein "SGP240" (anti-SOP) and a monoclonal anti-
body, directed against a distal tubular (+ collecting duct) epitope (MAK
12H12). Cysts in RPKD were negative for proximal but positive for the
distal marker. In early onset DPKD 30% of the cysts stained for the
proximal, and all other cysts were positive for the distal marker. In
adults with DPKD large cysts remained unstained by both of the
antibodies, however, focal epithelial hyperplasia (FEH), and all other
cysts were positive for the distal marker. In MCD cysts failed to react
with both the proximal and distal marker. Cysts in ARCD and FEH
were strongly labelled for the proximal marker (anti-SGP +); no cysts
of distal tubular origin could be identified. The data present evidence
that: (1.) immunohistochemistry applying anti-SGP/MAK 12 H 12 per-
mits differentiation between early onset KD and RKD, confirming the
current hypothesis on the origin of cysts in hereditary and dysplastic
renal disease; (2.) cysts in ARCD and FEH, but not in RPKD, are of
proximal tubular origin.
Lupus nephritis—reinterpretation in the light of novel serological
indicators? S. Kuster, K. Andrassy, and E. Ritz, Department of internal
Medicine, Heidelberg, Germany. Serological techniques for ANCA
(IF, proteinase-3-, myeloperoxidase-, lactoferrin-ab) together with
demonstration of SSA (Ro) and SSB (La) -ab have enlarged the scope
of diagnostic possibilities in SLE. In a retrospective study we analyzed
34 patients with biopsy-confirmed lupus nephritis. p-ANCA was posi-
tive in 31 of 34 patients, c-ANCA negative in all 34 patients. MPO-ab
were positive in 8/34 patients (titer < 2, > 10, normal < 2). Clinical
correlates for the presence of MPO-ab were necrotizing in glomerulo-
nephritis and/or cutaneous vasculitis. All patients with MPO-ab had
SSA/B ab (Wil-2 cells), but only 9 of the 26 patients without MPO-ab.
There was a striking correspondence between microsomal thyroid ab
(6/8) and MPO-ab. Patients with lupus nephritis had higher ds-DNS-ab,
but not higher ANA titers than SLE control patients without lupus
nephritis (by clinical examination). The lupus band test was positive in
SLE patients with as well as in those without renal involvement. In this
limited series the course of lupus nephritis was not more adverse in
those patients who had MPO-ab.
Transport systems at the cell membrane in the regulation of cell
proliferation by ras oncogene. F. Lang, E. Wöll, H. Weiss, F. Friedrich,
P. Dietl, S. Waldegger, K. Maly, and H. Grunicke, Institutes for
Physiology and Biochemistry, University of Innsbruck, Innsbruck,
Austria. The present study was performed to elucidate the involvement
of altered transport across the cell membrane in the stimulation of cell
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growth. Experiments were performed in 3T3 NIH fibroblasts trans-
fected with a transforming H-ras MMTV-LTR construct, expressing the
ras oncogene, which was point mutated at position 12, upon treatment
with 1 zmolIliter dexamethasone (+ras). Controls were transfected
cells not expressing the oncogene (—ras) and non-transfected cells
treated with dexamethasone (Oras). +ras, but not —ras or Oras grew in
serum depleted medium (0.5% serum). Expression of the ras oncogene
increased the activity of both the Na/H exchanger and Nat, K,
2C1 cotransport. The concerted action of these transport systems lead
to an increase of cell volume from 2816 22 fi (N = 6) to 4467 49 fi(N = 5). On the other hand, in +ras but not —ras and Oras, bradykinin,
bombesin or 0.5% fetal calf serum produced sustained oscillations of
cell membrane potential, due to intermittent activation of calcium-
sensitive K channels by oscillations of intracellular calcium activity.
The oscillations were abolished upon omission of extracellular calcium
and retarded by reduction of extracellular calcium. The oscillations
were inhibited by cadmium, lanthanum and 10 smol/liter nifedipine, but
not by 10 mol/liter verapamil, 10 mol/liter diltiazem and by I
tmolI1iter nifedipine. The oscillations are not significantly modified by
0.1 mmol/liter furosemide + 0.1 mmol/liter dimethyl-amiloride. The
proliferation of ras oncogene expressing cells in serum deprived media
is abolished in the presence of either 10 mol/liter nifedipine or 0.1
mmol/liter furosemide + 0.1 mmol/liter dimethylamiloride. In conclu-
sion, the expression of ras oncogene leads to profound alterations of ion
transport across the cell membrane and increase of cell volume, events
required for the stimulation of cellular proliferation.
Increased peritoneal ultrafiltration by tidal peritoneal dialysis. I.
Lubrich-Birkner, I. Keck, P. Schollmeyer, and H.B. Steinhauer, De-
partment of Internal Medicine, Division of Nephrology, University of
Freiburg, Freiburg, Germany. Long-term peritoneal dialysis is associ-
ated with a decline of ultrafiltration (UF) in many patients. To enhance
dialysis efficiency a modified intermittent peritoneal dialysis (IPD) was
created in which a constant reserve volume of dialysis fluid remains in
the peritoneal cavity, on top of which a tidal volume of dialysis solution
is exchanged (TPD, Twardowski, Proc 8th NatI Conf CAPD, Kansas
City 1988, pp. 156—166). In the present study, dialysis efficiency and
peritoneal protein loss in TPD were investigated in comparison to
conventional IPD. The tidal volume was chosen to be 50% of the total
filling volume. Seven patients with end-stage renal failure (6f, Im, age
67.3 6.3, x 5EM) undergoing IPD (11.1 1.8 months) took part in
this study. All patients were treated with IPD and TPD consecutively
for seven times each. Dialysate volume, dialysis time and dialysate
osmolality were equal in both forms of dialysis. No adverse effects were
observed during TPD treatment. Peritoneal ultrafiltration increased
from 3.91 0.78 mI/mm (IPD) to 4.71 0.91 mI/mm (TPD), P < 0.01.
Phosphate clearance rose from 8.42 0.93 mI/min/! .73 m2 (IPD) to 10.4
1.26 mI/mm/I .73 m2 (TPD), P < 0.05. Clearance rates of creatinine,
urea and potassium tended to increase in TPD (3—9%, NS). Dialysate
protein loss rose from 13.43 1.16 g (IPD) to 17.52 2.73 g per
treatment in TPD, P < 0.05. The present data indicate TPD to be an
acceptable dialysis therapy, providing efficient removal of fluid and
adequate peritoneal clearances.
Detection of human cytomegalovirus by the polymerase chain reaction
in rejected kidney grafts. J. Markovic-Lipkovski, C.A. Muller, W. Kuhn,
T. Risler, W. Lauchert, and GA. Muller, Medical University Clinics,
Departments 2 and 3, Surgery Clinics, Eberhard-Karis-University,
Tubingen, Germany. Human cytomegalovirus (HCMV) infections are
frequently associated with graft rejection in immunosuppressed patients
following organ transplantation. Twenty-three biopsies from rejected
kidneys and 11 samples from donor kidneys prior to transplantation
were analyzed for the presence of HCMV-DNA by the polymerase
chain reaction (PCR) and by immunohistochemistry. DNA extracted
from renal biopsies after proteinase K digestion was specifically ampli-
fied in 32 cycles using primers of the 147 bp DNA fragment of the
immediate early HCMV gene, and analyzed by slot-blot hybridization
with digoxigenine-labelled detection oligonucleotides. In this assay the
lowest reproducible sensitivity value for the HCMV-DNA detection
was 0.1 fg. Control experiments included 5 normal tissues as negative
and titrated HCMV plasmid DNA as positive controls. HCMV-DNA
was detected by PCR in a range from 0.1 fg up to 100.0 fg in 10 grafted
kidneys, which were rejected. Comparative immunohistological analy-
sis revealed HCMV in only 3 tissue sections. Furthermore, in 3 out of
II donor kidneys HCM V-DNA was also found by PCR analysis. These
results reveal that HCMV is often present in rejected kidneys and that
the infection can be transferred from the donor to the recipient. HCMV
is probably involved in causing and modulating local immune responses
in grafted kidneys. This work was supported by the DFG, Mu 523, and
by the Alexander von Humboldt-Foundation.
Immunophenotyping of dendritic cells in renal tissue. J. Markovic-
Lipkovski, C.A. Muller, G.A. Muller, Medical University Clinics,
Departments 2 and 3, Eberhard-Karls-University Tubingen, Tubingen,
Germany. Renal interstitial dendritic cells (RIDCs) express HLA class
II antigens. Further antigen cluster designations of these cells are still
undefined. To compare RIDCs with dendritic cells (DCs) from thymus
and from tonsils, monoclonal antibodies (Moabs) of the 4th Interna-
tional Workshop on Human Leukocyte Differentiation Antigens di-
rected against myeloid, as well as non-lineage NK cell antigens were
applied on cryostat section by indirect immunoperoxidase technique.
Renal tissue of 10 normal controls, 25 patients with glomerulonephntis
(GN) associated with interstitial cellular infiltrates and of 10 patients
with chronic pyelonephntis was investigated. All Moabs that reacted
with thymic or tonsillar DCs neither reacted with RIDCs of normal
kidneys nor with any interstitial infiltrating cells of kidneys with GN.
Several Moabs detecting the CD45, CD54 and CD55 antigens on
tonsillar DCs, as well as Moabs recognizing the CD14, CD25, CD35
antigen on tonsillar and on thymic DCs also detected DCs in "lympho-
follicle-like" structures of interstitial cellular infiltrates in chronic
pyelonephritis. DCs of different organs seemed to share only a few
common antigens. Organ-specific DCs probably have a distinct and
characteristic phenotype. Therefore, we failed to reveal Moabs which
reacted simultaneously with RIDC antigens of normal kidneys and with
DC antigens of thymus and tonsils. However, during certain renal
diseases, such as chronic pyelonephritis, DCs may accumulate in renal
interstitium. These DCs are not derived from the kidney, since they do
not express the same antigens as RIDCs of normal tissue. DCs likely
infiltrate renal tissue from the blood stream as other inflammatory cells.
This work was supported by the DFG, Mu 523/3—5 and the Alexander
von Homboldt-Foundation.
Plica cells: A new cell type in the proximal tubule of the human kidney.
R. Moll, M. Muller, and W. Thoenes, Institute of Pathology, University
Hospital Mainz, Mainz, Germany. Ten normal human kidneys were
immunohistochemically analyzed using antibodies against various cy-
tokeratins (CK) and vimentin. Besides the CK 8/18-expressing common
proximal tubular cells of the convoluted part, scattered small cells
(single or pairs) were observed on the basis of the additional expression
of CKs 7, 19 and vimentin. These small cells were usually situated
riding on plicae of the basement membrane caused by tubular bending.
The designation 'plica cells" is suggested. In electron microscopy they
differed from common tubular epithelial cells by light cytoplasm,
paucity of mitochondria, lack of the basal labyrinth and slightly
increased nuclear heterochromatin. Plica cells thus represent a quanti-
tatively minor, poorly-differentiated epithelial cell type of the convo-
luted part of the human proximal tubule which, to our knowledge, has
not yet been described. Their complex intermediate filament pattern is
typical for tubular cells with low degree of differentiation. As to their
significance, they may represent: (1) stem or reserve cells of the
proximal tubule; (2) malnourished cells due to the relatively large
distance from capillaries; (3) specialized cells with particularly well-
developed cytoskeleton which are able to resist to the increased
rheologic strain on the plicae of the tubular wall.
Localization of a novel antigen in intercalated cells of the collecting duct
using a human autoantibody. P. Mundel, P. Gilbert, M. Raghunath, and
W. Kriz, Inst it ut fur Anatomie und Zellbiologie der Universitdt, Heidel-
berg, Germany und Universitats-Kinderklinik, Zurich, Switzerland.
Serum from a 24-year-old woman with a history of habitual abortions
was applied to indirect immunofluorescence microscopy (1fF) of normal
human kidney frozen sections, where it revealed labeling of single cells
within the collecting and connecting tubules. No other renal structures
were stained. The same reaction pattern was noted in rat and rabbit
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kidney. On FITC- and PAP-labeled semithin frozen sections of perfu-
sionfixed rat kidney the immunoreactivity was found within the cyto-
plasm of intercalated cells (IC). The ultrastructural distribution of the
protein was examined after pre-embedding PAP-labeling and immuno-
electron microscopy of 40 m thick frozen sections from rat kidney.
The antigen was found in close topographical association with the studs
of tubulovesicular profiles and the cell membrane of IC. These studs
were shown to represent the cytoplasmic domain of a proton pump of
IC which is involved in the regulation of urine acidification by the
collecting duct. In Western blot experiments with detergent extracts
from rat kidney cortex or medulla, a protein with an apparent molecular
weight of 23 kD was detected by the autoantibody. However, the
antibody did not react with the purified proton pump (Dr. S. Gluck,
personal communication). In addition to the IC of the collecting duct,
this proton pump was detected in the proximal and distal tubule by hF,
whereas the 23 kD antigen was exclusively found in the IC of collecting
and connecting tubules. We conclude that the 23 kD proton defined by
a human autoantibody represents a new antigen being at least topo-
graphically associated with the proton pump of IC, but not being a part
of this enzyme.
Tumor necrosis factor-alpha and receptors for interleukin-2 in Wegen-
er's granulomatosis/nhicroscopic polyarteritis. I.L. Noronha, M. Eber-
lein-Gonska, K. Andrassy, R. Waldherr, Departments of Pathology and
Internal Medicine, University of Heidelberg, Heidelberg, Germany. In
ANCA-positive systemic vasculitis (Wegener's granulomatosis/micro-
scopic polyarteritis) tumor necrosis factor-alpha (TNFa) is supposed to
play an important role as mediator of the inflammatory reactions
promoting neutrophil degranulation and leading to activation of endo-
thelial cells. Receptors for interleukin 2 (IL-2R) are expressed after
immunological stimuli, and the interaction of IL-2 with its receptors is
fundamental for the action of IL-2 and subsequent clonal T-cell prolif-
eration. IL-2R are not only expressed on the cell membrane, but are
also released into the extracellular fluid. This soluble form of the IL-2R
(sIL-2R) can be measured in plasma samples. To assess the presence of
TNFa and IL-2R in systemic vasculitis we determined these mediators
in kidney biopsies as well as in the plasma. Cryostat sections from 19
patients with systemic vasculitis were examined by immunocytochem-
istry (APAAP method) using monoclonal antibodies against TNFa(Ceiltech CB0006) and IL-2R (Clonab Tu 69). The plasma levels of
TNFa and sIL-2R were assayed by means of an ELISA method (T-Cell
Sciences) at the time of biopsy. TNFa-positive infiltrating mononuclear
cells were observed in 15/19 cases and IL-2R positive cells were
detected in 16/19 biopsies. TNFa and IL-2R positive cells were local-
ized in the interstitium, in cellular crescents as well as surrounding
blood vessels (arterioles, small arteries and veins), Infiltrating positive
cells were also detected in vessel walls of arteries/arterioles exhibiting
acute necrosis. In addition, in situ hybridization studies demonstrated
an increased expression of mRNA for TNFs in infiltrating mononuclear
cells. With regard to TNFa determination in plasma samples, normal
individuals had consistently low TNFa levels, and in the majority of the
measurements it was undetectable (1.9 3.6 pg/mI; mean sD). Higher
TNFa plasma levels were observed in patients with vasculitis (58.1
98.31 pg/mI). When the 95% confidence interval was calculated for the
control group, plasma levels of TNFa higher than 10 pg/mI were
considered abnormal. By this definition, 7 patients showed elevated
TNFa levels. All patients with vasculitis presented a marked increase in
sIL-2R plasma levels when compared to normal controls (2602 361
U/mI vs. 361 133 U/mI; P <0.001). The number of TNFa and IL-2R
positive cells in renal tissue correlated neither with ANCA titers
(cANCA/pANCA) nor with the plasma levels at the time of biopsy. We
conclude that TNFa and IL-2R is produced by infiltrating cells in situ in
systemic ANCA-positive vasculitis and that they may represent impor-
tant mediators in the vasculitic process.
Adenine dinucleotides (Ap4A, Ap3A) from platelets activate phospholi-
pase C and phospholipase-A2 in mesangial cells. A. Ogilvie, X. Meyer, E.
Schulze-Lohoff, and R.B. Sterzel, Institut für Biochemie and Medizin,
Klinik IV, Universitdt Erlangen-Nürnberg, Germany. We have shown
that nucleotides (ATP, ADP) as well as the long-lived dinucleotides
Ap4A and Ap3A, which are both releasable from activated platelets,
stimulate the proliferation of cultured rat mesangial cells (MC) after 2—3
days. To elucidate the molecular mechanism of MC activation by
dinucleotides, receptor-dependent short-time effects were investigated:
(1.) activation of phospholipase C specific for inositol (P1-PLC): The
cells were labeled with tritiated inositol, and the intracellular inositol
phosphates (IP, 1P2, 1P3, IF4) were analyzed by ion exchange chroma-
tography. (2.) Activation of phospholipase A2 with secretion of POE2;
the prostaglandin was measured in the culture medium by means of a
specific RIA. Activation of P1-PLC by Ap4A und Ap3A (50—300 M) was
equivalent to the effects of ATP und ADP. Accumulation of 1P2 was
predominant whereas 1P3 increased only marginally, probably because
of a high rate of 1P3 degradation in MC. The liberation of POE2 by Ap4A
and Ap3A (100 M) was stimulated 20-fold over controls, which was
comparable to the effect of ATP at identical concentrations. It is unclear
whether adenine dinucleotides have their own receptors on MC or
whether they bind to the well-known purine receptor (P2 subtype).
Alternatively, ectohydrolases of intact MC are able to degrade Ap4A
yielding ATP in the extracellular milieu. ATP could then be the ultimate
agonist via the P2-receptor. Such an agonistic function of the dinucle-
otides, which is dependent on hydrolases, seems probable for MC since
cells with weak ecto-Ap4Aase activity (such as arterial smooth muscle
cells) did not respond to the dinucleotides but were normally activated
by ATP and ADP. The results suggest a specific function of adenine
dinucleotides for the activation of MC, which may play a role in
glomerular inflammation.
Closed loop analysis of the blood pressure regulatory function of the
kidney in conscious dogs. PB. Persson, H. Ehmke, M. Lempinen, B.
Nafz, and H.R. Kirchheim, I. Physiologisches Institut, Heidelberg,
Germany. The renin-angiotensin system (RAS) plays an important role
in medium to long-term blood pressure control. This was indicated by a
close correlation between mean arterial pressure (MAP) and the param-
eters characterizing pressure-dependent renin release. To prove a
causal relationship, the ability of the kidney to compensate a defined
reduction in MAP should be tested. The conventional approach has
been to reduce renal artery pressure (RAP) to a fixed level, and to see
how much MAP increases (open loop analysis). However, under
physiological conditions the kidney is able to sense the pressure
increase which is caused by the activation of the RAS. To quantify the
role of the RAS under physiological conditions an electro-pneumatic
feedback device was designed to enable a closed loop analysis. A
catheter was placed into the thoracic aorta. A pneumatic occiuder was
implanted around the aorta distal to this catheter but upstream of the
origin of the renal arteries. Another catheter was positioned below the
origin of the renal arteries. A pressure difference of 20 mm Hg was
maintained in 8 experiments on 6 conscious foxhounds for 3 hours
(starting pressure: MAP: 104 9 mm Hg; RAP: 84 10 mm Hg). The
kidney was capable of determining arterial pressure according to its
own demands, that is, the RAP pressure drop was almost totally
compensated for, reaching 101 10 mm Hg after 180 mm. Hence, the
closed loop gain was close to 1. Converting enzyme inhibition blocked
this response. Therefore, an important role of pressure dependent
renin-release in determining blood pressure is suggested. This study
was supported by the German Research Foundation within the For-
schergruppe Niere.
Angiotensin II (Ang II) stimulation of phospholipase D (PLD) in rat
renal mesangial cells (MC) is mediated by the AT1 receptor subtype. J.
Pfeilschi'fter, A. Huwiler, and C. Merriweather, Research Department,
Pharmaceuticals Division, Ciba-Geigy Ltd, Base!, Switzerland. The
development of specific Ang II receptor antagonists has revealed two
distinct Ang II receptors, designated as AT1 and AT2. Ang II stimulated
a biphasic 1 ,2-diacylglycerol formation in [3H]arachidonic acid labelled
MC. In contrast, in cells labelled with [3Hjmyristic acid, a tracer that
preferentially marks phosphatidylcholine, Ang II induced a delayed
monophasic production of I ,2-diacylglycerol. This delayed peak of
I ,2-diacylglycerol generation was associated with a concomitant in-
crease in choline formation, suggesting that stimulation of MC with Ang
II causes a PLD-mediated phosphatidylcholine hydrolysis. This con-
clusion is supported by the observation that Ang II stimulated the
accumulation of phosphatidylethanol, when ethanol was added to MC.
The production of choline and phosphatidylethanol stimulated by Ang
H was completely blocked by the AT1 receptor selective antagonist
DuP 753 with an IC50 of 8 n, but not by the AT2 receptor selective
ligand CGP 421 12A. Furthermore, angiotensin (1—7) and angiotensin
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(1—6) had only weak effects on choline generation. These data clearly
indicate that AT1 receptors trigger PLD-mediated phosphatidylcholine
hydrolysis in MC.
Chronic blockade of PAF receptor: Influence in experimental diabetic
nephropathy. A. Radounikli, R.A.K. Stahl, S. Harendza, M.J. Mi-
hatsch, U. Brecht, W. Schoeppe, and F. Thaiss, University Hospitals,
Frankfurt, Germany and Base!, Switzerland, and Boehringer In-
ge!heim, Inge!heim, Germany. To study the possible role of platelet
activating factor (PAF) in experimental diabetic nephropathy, diabetic
rats were treated with the PAF receptor blocker WEB 2170. Diabetes
was induced in Wistar rats by the i.v. injection of streptocotocin (STC).
The PAF-receptor blocker (WEB 2170) was given in the drinking water
(1 g/l) immediately after STC injection. The following parameters were
examined 7 days and 3 months after induction of STC-diabetes:
albuminuria (Aur: mg/24 hr), inulin and PAH clearances (C1,, and CPAH:
pi/min/100 g body wt), glomerular PGE2 and TxB2 formation (pg/
mm/mg protein). In addition semiquantitative morphologic analysis was
performed. WEB 2170 did not change Aur (STC + WEB 0.6 0.2, STC
0.5 0.2) and C1,, (STC + WEB 560 66, STC 515 50) 7 days after
induction of STC diabetes. At 3 months Aur (STC + WEB 0.7 0.1,
STC 1.0 0.3), C1 (STC + WEB 511 51, STC 574 77) and
glomerular POE2 and TxB2 formation were not altered by WEB 2170.
No effect was seen on blood glucose levels (STC + WEB 239 55, STC
241 48 mg%). CPAH and filtration fraction (FF%) were, however,
significantly changed (P < 0.01) in STC diabetic rats by WEB [(CPAH):
STC + WEB 2188 340, STC 850 200; (FF%): STC + WEB 23 3,
STC 85 17]. The results demonstrate that a PAF receptor blocker
improves CPAH and FF in chronic STC diabetic nephropathy. Thus
PAF might play a role in hemodynamic regulation of experimental
diabetic nephropathy.
Hyperparathyroidism in long-term hemodialysis (HD) patients. H.
Reiche!, M. Ki!burg, E. Ritz, Department of Internal Medicine, Divi-
sion of Nephrology, Heidelberg, Germany. The mechanisms causing
secondary hyperparathyroidism (HPT) in end-stage renal disease are
not completely understood. In particular, the role of reduced circulating
1 ,25(OH)2D3 in impaired suppression of parathyroid glands is not
clarified. It is currently under discussion whether vitamin D (or active
vitamin D metabolites) should be given for prophylaxis of HPT.
Parathyroidectomy (P'FX) is frequently needed after 10 years HD (24%
of patients, EDTA registry 1989). In other series the prevalence of PTX
was more than 50% after 10 years HD. We, therefore, examined in our
patients the 26 subjects who were on maintenance HD longer than 10
years. Vitamin D or I ,25(OH)2D3 (0.25 pg/day) were routinely admin-
istered except to hypercalcemic patients (vitamin D therapy in 19/26
patients), The prevalence of aluminum (Al) overload was low (DFO
therapy in 4/26 subjects). The frequency of PTX was 7.7% (2/26
patients). Median plasma intact PTH (without PTX patients) was 14.0
pmol/liter (range 1.0-65.0); the median serum phosphate level was 1.78
mmol/liter (range 1,11—2.71). Dialysate calcium concentration was 1.75
mmol. Conclusion: The data support the efficacy of prophylaxis of HPT
by vitamin D metabolites. Future studies should focus on the dose of
vitamin D metabolites. In a large proportion of our patients (11/26),
intact PTH was below 6 pmol/l. This may contribute to reduced bone
turnover.
Is the contraction of mesangial cells upon the addition of angiotensin II
modulated by interleukin-1 and tumor necrosis factor-a? P.M. Rob, S.
GieJ3elmann, and J. Pfeilsch,fter, Medizinische Universitãt zu Lflbeck,
BRD; Ciba-Geigy, Base!, Switzerland. Recently it was shown that
IL-1/3 and TNFa increase the cGMP synthesis in mesangial cells (MC).
We investigated whether IL-1/3 and TNFa can modulate the contraction
of MC after angiotensin II (Ang H) stimulation. Cells from rat kidneys
were characterized morphologically and cytochemically as MC and
were grown in 20% fetal calf serum, 0.65 lU/liter insulin and 2.2 g/liter
sodium bicarbonate at 37°C. MC were incubated for 24 hr with and
without IL-113 (1 nM) and TNFa (1 nM) alone, with or without
indometacin (500 nM) or N°-nitro-L-arginine (L-NNA, I nM). Contrac-
tions of MC were evaluated by using a phase contrast microscope to
which a camera was adapted. Phase micrographs were taken before (t0)
and at 3 mm (t3) after the addition of 10 ni Ang II. Representative
measurements of the cell surface area at to and t3 were done using a
Kontron digitizer tablet. A decrease of the cellular dimensions between
and t3 > 12% was defined as a contraction. The test was used to
compare the treatment groups with their respective control group. With
Ang II, 32/59 (54%) of MC contracted. Furthermore, indometacin or
L-NNA could not alter the contractile response following Ang H. With
IL-113 and TNFc only 6/55 (11%) and 9/64(14%) of cells contracted. The
inhibition of contraction by IL-1f3 was significantly diminished by
L-NNA (6/55 vs. 14/42); with TNFa the effect of L-NNA was less
expressed. IL-113 and TNFa inhibited significantly the contraction of
MC induced by Ang II. IL-l/3 an TNFa were shown to stimulate NO
synthase in MC. The effect of IL-l/3 was inhibited by L-NNA, which is
an inhibitor of NO synthase. The present data suggest that IL-113 and
TNFa induce NO synthase in mesangial cells and thereby alter the
contractile responsiveness of the cells.
Total hip replacement after kidney transplantation. A long term
follow-up of 81 hips from 1972 to 1990. J. Romero, A. Schreiber, U.
Binswanger, Department of Orthopedic Surgery and Internal Medicine,
University of Zurich, School of Medicine, Zurich, Switzerland. In
Zurich, 1313 kidney allotransplantations were performed from 1964 to
1990. Disabling osteonecrosis occurred in about 10% after kidney
transplantation. The hip was the most common site to be involved.
Numerous operative and non-operative treatments were attempted to
reverse the necrotic process in the femoral head. However, in immu-
nosuppressed patients with steroid-related osteonecrosis, poor results
have been obtained. We report the results of 81 total hip replacements
that were performed from 1972 to 1990 in 54 steroid-dependent renal
transplant recipients (age: range 20—64 years; median 44 years). Seven-
ty-seven hips had a cemented total replacement (27 unilateral, 25
bilateral), 4 a cementless one (2 bilateral). The average follow-up is 8.1
years (range 1—18 years), Survivor tables for prostheses and patients
were constructed using the method described by Cutler and Ederer (J
Chron Dis 1958). There were no complications during the operation and
no patient died in the early follow-up period. A low rate of early general
complications occurred (1 reversible host-versus-renal graft-reaction, I
minor myocardial infarction). There were no deep infections. Seven
hips in five patients required revision surgery after a mean of 11.4 years
(range 7.4—13.7 years) due to aseptic loosening. Twenty-two patients
have died so far from causes unrelated for their orthopedic treatment.
The overall probability of survival after 15 years is 52.8% for patients
and 38.2% for prosthesis, after 18 years 39.6% and 38.2%, respectively.
We conclude that total hip replacement in kidney transplant recipients
with osteonecrosis of the femoral head following immunosuppression is
safe and has an excellent outcome, despite the presence of steroid-
induced osteoporosis and renal osteodystrophy. According to other
authors (Bradford, CORR 1983; Radford, JBJS 1989) it will remain the
treatment of choice even in the young patient. With the improvement of
immunosuppression, renal transplant recipients have an increased life
expectancy. Statistically they have now a higher risk to undergo
revision surgery after arthroplasty than to die because of their renal
disease. For this reason we started in 1990 to perform cementless total
hip arthroplasty in young patients after kidney transplantation.
Dopamine (DA)2 receptor activation inhibits noradrenaline release
from human renal sympathetic nerves. L.C. Rump, E. Schwertfeger,
M,J. Schuster, and P. Schol!meyer, Department of Medicine IV,
University of Freiburg, Freiburg, Germany. Dopamine (DA) receptor
modulation of noradrenaline (NA) release from human renal sympa-
thetic nerves was studied. Cortical kidney slices (19.6 0.4 mg, N =
154) were incubated with 3H-NA and stimulated twice (SI and S2 at 5
Hz for 60 seconds) in superfusion chambers by platinum electrodes.
The slices stored radioactivity (115500 3500 dpm/mg). The stimula-
tion induced (S-I) outflow of radioactivity was 1.19 0.06% of the total
tissue radioactivity. Separation of °H-NA from its metabolites showed
that 62.8 1.4% (N = 4) of the S-I outflow was intact 3H-NA.
Pretreatment of 6-OH-DA to destroy sympathetic nerve terminals
reduced the uptake of radioactivity to 33100 7700 dpm/mg (N = 4).
6-OH-DA pretreatment, omission of Ca + and addition of tetrodotoxin
(1 /sM) abolished S-I outflow of radioactivity. The DA1 receptor agonist
fenoldopam (1 M) increased S-I outflow to 138.9 13.4% (N = 7),
whereas the DA2 receptor agonist quinpirole (1 LM) inhibited NA
release to 44.7 9.9% (N = 5) as compared to control of 106.0 5.5%(N = 19). The facilitatory effect of fenoldopam was not observed in the
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presence of the -adrenoceptor blocker phentolainine (1 /.LM). Phentol-
amine by itself enhanced S-I outflow to 147.8 14.6% (N = 6). The
inhibitory effect of quinpirole was blocked by the DA2 receptor antag-
onist sulpiride (10 M) but not by the DA1 receptor antagonist SCH
23390 (1 SM). The superfused cortical kidney slice is a valid technique
to study modulation of NA release from human renal sympathetic
nerves. Activation of prejunctional DA2 but not DA1 receptors inhibits
NA release in human renal cortex.
[32P] uptake by the proximal convoluted (PCT) and straight (PST)
tubule cells isolated from rat kidney. A. Rybczy,iska, M. Wasewicz, G.
Kuchta, and A. Hoppe, Department of din. Biochem. MedicalAcad-
emy, Gda,isk, Germany. The major disadvantage of transport studies
on isolated tubules is the limited access of the luminal face to trans-
ported substance(s). The aim of the present study was to develop a
method of isolation of cells enriched by PCT and PST cells. The kidneys
of penthobarbital anaesthetized rat were perfused by a cold "intracel-
lular-like" solution (ICS): K 75, P04 1, glucose 180, HC03 9, HEPES
5 mM, pH 7.4. Cortex (C) and outer stripe of the outer medulla (OS)
were dissected. Slices were minced and sieved through the 250, 80, and
40 m nylon meshes. The pellets were suspended in ice-cold 40 and
30% solution of Percoll in ICS, respectively, and after the centrifugation
at 25,000 g 20 mm the bottom layer contained a viable cells (90.0
1.2%) as tested with a Trypan blue exclusion. The glutamine synthetase
activity, a marker for a PST, was markedly higher in cells obtained from
the OS if compared to those from C: 48 3 vs. 13 3 g Pi/min/mg
protein as well as gamma-glutamyltranspeptidase: 33.5 0.02vs. 7.5
1.3 U/mg protein. Not less than 80% of total Pi uptake (measured at
37°C) represented the Na-dependent Pi uptake which was sensitive to
inhibitory effect of PTH.
PTH U/mI 0 0.27 0.54 0.81
OS 332 332 257° 206°
C 479 533 437 283
a P < 0.001 vs. 0 PTH
In conclusion, the described method allow us to isolate enriched
fractions of viable and functionally integrated cells originating from
PCT or PST. The PST cells seem to be more sensitive to PTH.
Aldose reductase (AR) activity and soi-bitol synthesis (SS) in cell culture
of different tubular parts. A. Schellenberg, I. Schubert, C. Schwoerbel,
S. Hansen-Schmidt, R. W. Grunewald, H.E. Franz, Sektion Nephrol-
ogie, Universitat Ulm, Ulm, Germany, Organic osmolytes such as
sorbitol play an important role in osmoregulation of inner medullary
duct cells (IMCD). The enzymes of sorbitol synthesis (AR) and metab-
olism (SDH = sorbitol dehydrogenase) can be found in cortex, outer
and inner medulla. Assuming an osmotic enzyme induction IMCD, PT
(proximal tubuli), and TALH (thick ascending limb) cells were cultured
for 6 days in media of 300 and 600 m0smlliter (osmolarity adjusted by
NaCI and urea). All cell types showed highest AR activity in 600
mOsm/liter NaCI (IMCD 274 28; TALH 70 16; PT 75 11 U/g
prot). Much lower activities were found in 600 m0smlliter urea (IMCD
81 8;TALH 4 1; PT 8 1 U/g prot.) and in 300 mOsm/liter (IMCD
89 10; TALH 5 2; PT 6 I U/g prot). Similar alterations were
observed in SS. These results suggest that SS in PT and TALH cells is
regulated by extracellular osmolarity. IMCD cells showed high AR
activity even at low osmolarities.
Immunoscintigraphy of human renal tumors using Tc-99m-monoclonal
antibody 138H11 in an extracorporeal perfusion model. J.E. Scherber-
ich, M. Tauber, P. Fischer, R.P. Baum, W. Boeckmann, S. Weier, S.
StOrkel, W. Schoeppe, Departments of Nephrology, Nuclear Medicine,
Urology, Pathology, University Mainz, University Hospital, Frankfurt
am Main, Germany. To evaluate tissue-specific binding of the murine
monoclonal antibody (MAB) 138H1 I of IgG1 class, directed against a
membrane surface epitope of renal tumors (Scherberich/Fischer 1990),
the MAB was labeled with Tc-99m according to the method of Schwarz,
resulting in a labeling efficiency of >97% (Baum et al). After nephrec-
tomy, tumor bearing kidneys were perfused with I mg of the Tc-99m
labelled MAB (300 MBq) in Euro-Collins solution according to the
model reported by van Dijk et al, 1988. Planar scintigraphic as well as
SPECT images were performed, where a specific uptake of the Tc-99m
labeled l38Hl 1-MAB was demonstrated in renal cancer of clear cell and
chromophilic cell type, but not of chromophobic (and oncocytoma) cell
type. Tumor to normal renal cortex uptake ratio was 7-20:1 (N = 7); no
uptake was observed with Tc-99m anti-CEA-MAB or unspecific IgG as
controls. The scintigraphic data were confirmed by immunohistochem-
ical analysis of tissue sections and further supported our previous
results on the specificity of 138H1 1-MAB for renal cancer originating
from segments of the proximal tubule, indicating possible use of the
MAB for staging and follow-up.
Normo- and microalbuminuric patients with type I diabetes mellitus:
Changes of glomerular and tubular markers after ergometric exercise vs.
controls and the influence of captopril. fE. Scherberich, G. Aulmann,
W. Kdmpf, E. Jungmann, W. Schoeppe, Departments of Nephrology/
Endocrinology, University Hospital, Frankfurt am Main, Germany. To
elucidate possible modulative effects of ACE inhibitors on exercise
induced proteinuria in normotensive patients (pts.) with IDDM, the
excretion of albumin (RIA), a-l-microglobulin (a1m), glomerular and
tubular enzymes, and creatinine clearance (Car) were assessed in 8 pts.
(mean age 30 years) with IDDM but normal albumin excretion (<20
gImin, HbAlc 6.5%), in 10 pts (x: 34 years) with_microatbuminuria
(UAE 20—200 /min, HbAlc 6.9%) vs. 6 controls (x 28 years), before
and after standardized ergometry (6 mm). In a double-blind trial
pts/controls received either 25 mg Captopril (CPL) or placebo 1 hr
before exercise. In normoalbuminuric pts. CPL reduced exercise in-
duced rise of urinary albumin and a1m (<0.05 vs. placebo), and lowered
exercise related decrease in urinary enzyme:creatinine ratio (DAP-IV,
ATA, P < 0.05, vs. placebo). In microalbuminuric pts. basal as well as
exercise induced albuminuria and a1m excretion was lower after CPL
(P < 0.05 vs. placebo). In controls after ergometry CPL (vs. placebo)
converted the enzyme:creatinine ratio, a finding never seen in the two
groups of pts. No changes in blood pressure and Ccr were noticed. The
data indicate that CPL modulates renal handling of proteins and may
exert a beneficial effect on exercised induced (micro-)proteinuria and
enzymuria in pts. with early onset IDDM, not to be explained by
changes of systemic blood pressure.
Effects of complement activation on the renal microcirculation. K.
Schlottmann, E. Gulbins, E. W. Rauterberg, and M. Steinhausen,
Institute of Physiology, University of Heidelberg, Heidelberg, and
German Diagnostic Clinic, Wiesbaden, Germany. To elucidate the
mechanism of action of inflammatory mediators on the renal microcir-
culation we applicated cobra venom factor (CVF) i.v., an activator of
the alternative pathway. We utilized creatinine clearance and flowmeter
measurements on the normal rat kidney and intravital microscopy on
the model of the split hydronephrotic rat kidney. Bolus of CVF (1 IU/lO
g body wt) in inactin-anaesthetized female Wistar rats (N = 5) resulted
in immediate reduction of renal blood flow (RB F) (—68% after 10 mm),
which remained decreased until the end of experiments (—32% after 90
mm). Systemic blood pressure (BP) was significantly reduced only in
the early period (—23% from control value 126 mm Hg after 10 mm).
After an initial anuric phase the glomerular filtration rate (GFR) was
significantly diminished by 60% after 40 mm and by 47% after 90 mm.
Hematocrit (HCT) increased significantly from 44% to 47% after 90
mm; the white blood count (WBC) was reduced by about 50%.
Application of the competitive thromboxane A2 (TXA2) antagonist
Daltroban (BM 13505) revealed a complete inhibition of all renal and
systemical CVF effects, while HCT and WBC showed the same
reduction as with single CVF. Infusion of the competitive leukotriene
C4/D4 antagonist ICI 198615 resulted in an attenuation of late renal CVF
effects, that is, 30 mm after CVF injection and later. HCT and WBC
remained unaffected. The localization of the CVF effects in the split
hydronephrotic rat kidney showed a massive constriction in large
preglomerular vessels with a strong fall in glomerular blood flow. The
afferent arterioles—most sensitive to many vasoconstricting hor-
mones—were not constricted. Our results suggest an early release of
high amounts of anaphylatoxins (C3a, C5a) in the early period of CVF
action with consecutive release of TXA2 and in a later period release of
TXA2 and cysteinyl-leukotrienes. In previous studies we showed a
similar severe vasoconstriction in large preglomerular vessels under
cysteinyl-leukotnenes (Eur J dim Invest 21:184—196, 1991. This study
was supported by DFG-Forschergruppe Niere).
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Simultaneous detection of NaIK-ATPase inhibition and vasopressor
activity in hypertensive plasma. H. Schiuter, K. Biel, K.H. Rahn, and
W. Zidek, Medical University-Poliklinik Mbnster, Munster, Germany.
The role of a circulating NaJK-ATPase inhibitor in the pathogenesis of
primary hypertension is currently being discussed. As it is questionable
whether NaIK-ATPase inhibition is the principal mechanism underlying
vasoconstriction in primary hypertension, we tested plasma fractions of
essential hypertensives (N = 10) and normotensives (N = 10) obtained
by gel chromatography for both NaJK-ATPase inhibition and vasoac-
tivity. Na/K-ATPase activity was measured as described by Hamlyn et
al (1982), vasopressor activity was assessed by measuring vascular
resistance in the isolated perfused rat kidney. After deproteinization
and gel chromatography with Biogel P2 a high molecular (1000—1500 Da)
(hypertensive plasma: 60 40% NaJK-ATPase activity; normotensive
plasma: 72 18% NaJK-ATPase activity) and a low molecular fraction
(200—600 Da) (hypertensive plasma: 63 37% NaJK-ATPase activity;
normotensive plasma: 92 8% Na/K-ATPase activity; P < 0.01)
inhibiting the Na/K-ATPase appeared. The NaJK-ATPase inhibition
was more pronounced in hypertensives in both fractions. Vasopressor
activity was found in a fraction within the 1500—2000 Da range, which
was more pronounced in hypertensives, too (hypertensive plasma: 36
mm Hg; normotensive plasma 11 2 mm Hg; P < 0,01). It appears that
vasopressor activity in plasma from essential hypertensives does not
coincide with NaJK-ATPase inhibition after chromatographic separa-
tion. Thus the circulating vasopressor agent in essential hypertension
may be different from the NaJK-ATPase inhibitor.
Erythropoietin in CAPD: Follow-up study of peritoneal membrane
function. H. Schmitt, N. Schongen, J. Riehl, U. Gladziwa, A. Skrast-
ing, B. Ehmer, and H.G. Sieberth, Department of Internal Medicine II
and Department of Clinical Chemistry, Technical University Aachen;
Boehringer Mannheim GmbH; Germany. As a positive side-effect an
increase in peritoneal ultrafiltration has been described during s.c. EPO
treatment in CAPD patients (Nephron 53:91, 1989). We carried out a
follow-up study in 8 CAPD patients undergoing s.c. EPO therapy (2f,
6m; mean age 54.5 10.5 years; duration of CAPD 21.5 5.6 months).
The patients received an initial dose of 5—20 U/kg body wt/day which
was increased until the target hematocrit of 35% was reached (follow-up
period 6—20 months). After start of EPO therapy several parameters of
peritoneal membrane function were evaluated regularly, at first in a two
week interval followed by a three week interval from the third month of
treatment. Peritoneal ultrafiltration was measured under standardized
conditions (dialysate exchange with 2 1 2.27 glucose, dwell time 4 h).
Furthermore, we determined the clearance rates of urea, creatinine,
phosphate, /32-microglobulin, albumin, IgG and ferritin (serial effluent
specimens within 24 h).
Time from start of EPO therapy months
0 1 2
Clearance mI/mm
Urea 6.60 1.91 6.72 2.01 6.51 1.85
Creatinine 5.12 1.79 5.20 1.88 4.98 1.82
Phosphate 4.18 1.42 3.97 1.32 4.05 1.35
/32-microgl. 1.15 0.42 1.20 0.45 1.12 0.41
Ultrafiltration ml 306 111 320 102 299 98




Urea 6.49 1.92 6.64 1.88
Creatinine 5.01 1.72 5.23 1.90
Phosphate 4.10 1.29 4.25 1.39
32-microgl. 1.08 0.39 1.09 0.40
Ultrafiltration ml 296 100 308 105
Similar results were obtained for albumin, lgG and ferritin. In conclu-
sion, we did not find any significant change in peritoneal ultrafiltration
and clearance rates during EPO treatment.
Calcium channel blockers dissociate pressure-dependent renin secre-
tion from renal autoregulation of flow. H. Scholz and A. Kurtz, Physi-
ologisches Institut der Universität, Zurich, Switzerland and Inst itut für
Physiologie I, Universitat Regensburg, Germany. Renal perfusion
pressure evokes two physiologically relevant responses of the renal
vasculature: (1.) Increasing renal artery pressure causes an increase of
renal vascular tone, thus leading to uncoupling of renal blood flow from
perfusion pressure (renal autoregulation). (2.) Renin secretion from
renal juxtaglomerular (JG) cells which is inversely correlated with renal
artery pressure (renal "baroreceptor"). Using the model of isolated
perfused rat kidneys, we examined whether or not pressure-dependent
renin secretion from renal JG cells which are metaplastically trans-
formed vascular smooth muscle cells is functionally linked to autoreg-
ulation of renal flow. Isolated rat kidneys were perfused in a recycling
system with a synthetic medium containing albumin (6 gldl) and human
red cells (10% Hct). Perfusion pressure was adjusted to different values
between 40 and 160mm Hg by means of a feedback-regulated peristaltic
pump. Renal autoregulation of perfusate flow was well preserved in the
pressure range between 80 and 160 mm Hg (flow rate 14.5 0.5 to 15.0
0.8 ml min 'g). At 100mm Hg renin secretory rates were 8.5
3.5 (ng ANGI hr) min' 'g. A stepwise reduction of renal artery
pressure resulted in an exponential increase of renin release yielding a
10-fold stimulation at 40 mm Hg versus 100 mm Hg. Nifedipine (5 SM),
nitrendipine (3 zM), and verapamil (5 SM), three structurally distinct
calcium channel blockers, blunted renal autoregulation of flow, but at
the same time did not affect pressure-regulated renin release. In
addition, the calcium channel agonist Bay K 8644 caused strong and
persistent renal vasoconstriction but had no significant effect on pres-
sure-regulated renin release. Thus, our findings indicate that voltage-
operated calcium channels are involved in renal autoregulation of flow
but not in pressure control of renin secretion. In consequence, the
myogenic control of renal vascular tone and the regulation of renin
secretion appear not to be functionally linked, but they are possibly
under the control of different cellular signal transduction pathways.
Comparative therapeutic and histological effects of intravenous urodil-
atm or nitroprusside combined with dopamine during established acute
renal failure in rats. S. Shaw and P. Weidmann, Medizinische Polik-
linik, University of Bern, Switzerland. Intravenous (i.v.) infusion of
urodilatin, a peptide analogue of ANF99126, can improve renal impair-
ment when given together with dopamine during established ischemic
acute renal failure in the rat (EARF). To define histological correlates of
protection and assess potential therapeutic actions of other vasodilators
whose action, like that of urodilatin, may be partly mediated by cyclic
GMP, i.v. infusions of urodilatin and dopamine (UD) were compared
with nitroprusside and dopamine (ND). Twenty-four hours after 30 mm
of bilateral renal artery occlusion, carotid artery, jugular vein and
bladder cannulae were inserted and separate groups of animals (N = 6)
received 5 hr iv. infusions of either (a) synthetic urodilatin acetate
(Bissendorf Peptide GmbH, Wedemark, Germany) (0.67 zg/kg/min)
plus dopamine at a mean dose of 40 7 .sg/kg/min sufficient to maintain
mean arterial pressure (MAP) at 112 1 mm Hg, or (b) nitroprusside (7
sg/kg/min) and dopamine at a mean dose of 35 7 jsg/kg/min (MAP 108
4 mm Hg). Plasma creatinine (Per), MAP, C'4-inulin clearance
(GFR), urine volume (Uv), fractional excretion of sodium (FENa+) and
potassium (FEK*) were monitored. Urinary losses were replaced by
saline. At the end of infusion, PCr was measured, the bladder was
sutured and animals were recovered for a further 19 hr to evaluate
longer term effect of treatments. The following day (48 hr after
induction of ARF) 1Cr was measured and the left kidney fixed in 10%
formalin for semi-quantitative histological evaluation. All values are
mean SEM. During i.v. infusion of UD, GFR, Uv and FEN*
progressively increased from 0.24 0.04 to 1.0 0.16 mI/mm, 1.4 0.2
to 8.3 mi/hr and from 2.9 0.5 to 15.8 2.4%, respectively (P <
0.001). Cr and FEK÷ decreased from 230 16 to 135 18 mol/liter
and 89 12 to 48 6% (P < 0.001). Nineteen hours after the end of
infusion (i.e. 48 hr after ischemic injury) Cr remained significantly
reduced (106 14 mol/liter) compared to nontreated animals (274 22
smoI/liter, P < 0.001). In contrast, a five hour i.v. infusion of ND only
minimally increased GFR (0.2 0.3 to 0.4 0.5 mI/mm, P < 0.05),
FENa+ (2.3 0.3 to 7.2 1%, P <0.05) and Uv (0.9 0.1 to 2.7 0.4
ml/hr, P < 0.01) and slightly reduced 1Cr from 237 23 to 195 21
zmol/liter (not significant). Twenty-four hours later, 1cr levels in ND
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treated animals had risen again to 230 34 molI1iter. Histologically,
UD-treatment markedly reduced (P < 0.05) the incidence of tubular
desquamation, necrosis and granular casts in cortical areas compared to
ND. Conclusion. The superior effectiveness of i.v. UD compared to ND
in improving renal function during EARF suggests that selective rather
than generalized alterations in cGMP may underly its beneficial action.
Recovery of renal function occurs slowly over 5 hr, is sustained after
the infusion and is associated with marked histological improvements
mainly in cortical regions.
Biochemical functions of red blood cells (RBC) of hemodialysis (HD)
patients with erythropoietin (EPO) therapy. W. Siems, T. Grune, H.
Hampi, G. Wendel, and E. Riedel, Freie Universitdt and Humboldt
Universität Berlin, Institute of Biochemistry, Berlin, Germany. Therapy
of anemia of HD patients with EPO leads to improvements of protein
metabolism but also to unexpected effects, such as hypertension. The
aim of our study was to clarify the biochemical pattern of RBC of HD
patients without (N = 12) and after EPO therapy (N = 18) compared to
a healthy control group (N = 19) due to the importance of RBC for
energy metabolism and blood viscosity. We measured median densities



























a P (control) <0.05, b P (without/with EPO) <0.05.
The significantly increased nucleotide pattern and enzyme content in
RBC of HD patients after EPO therapy reflect the rejuvenation of cell
population and correlate with enhanced deformabilities and therefore a
better fluidity. Thus, EPO therapy leads to improved biochemical
functions of RBC in HD patients.
Use of the polymerase chain reaction (PCR) for the detection of Na/H
exchanger mRNA in human blood cells and rat tissues. W. Siffert and B.
Quednau, Max-Planck-Institut für Biophysik, Frankfurt/Main, Ger-
many. Many recent reports suggest an overexpression of Na/H
exchange activity in essential hypertension (EHT). The molecular basis
of this observation has remained obscure although kinetic data may
argue in favor of an overexpression of transport protein in EHT.
Studies on the expression of the Na/H exchanger are complicated by
the lack of adequate sensitivity of standard methods (such as Northern
blotting) for the detection of specific low abundance mRNA. Using
reverse transcription-PCR we have examined the expression of
Na/H exchanger-specific transcripts in human lymphocytes and
polymorphonuclear cells (PMN5), and in rat thymus, heart and kidney.
RNA was reverse transcribed specifically and then amplified by PCR
using two specific oligonucleotide primers. In human blood cells a
single major DNA band was obtained. The identity of the PCR product
was confirmed by restriction enzyme analysis and by hybridization with
a specific oligonucleotide. In rat tissues the PCR product was distinctly
larger and after restriction two DNA bands of unexpected length were
obtained. Hence, the sequence of the rat Na/H exchanger appears to
differ from that of humans. These results should provide a basis for the
development of a PCR assay for the quantification of Na/H exchang-
er-specific mRNA in small cell and tissue samples.
Effect of rapidly increasing papillary osmolality on organic osmolytes
after chronic furosemide treatment. M. Sone, K. Thurau, and F.X.
Beck, Physiologisches institut der Universitãt, München, Germany.
The aim of this study was to elucidate the effect of a rapid increase in
papillary tonicity on medullary organic osmolytes and cell osmoadap-
tation after chronic lowering of extracellular electrolyte concentrations
and organic osmolytes in the renal papilla. Experiments were per-
formed on 3 groups of male Wistar rats: group 1-controls (treated only
with furosemide-vehicle), group 2-treatment with furosemide (0.5 mg/
hr/100 g body wt) for 6 days via osmotic minipumps, group 3-furo-
semide for 6 days and subsequent infusion of ddAVP (2 ng/hr/100 g
body wt) for 2 hours. Organic osmolytes (glycerophosphorylcholine,
betaine, myo-inositol, sorbitol) were measured in homogenates of the
various zones of the kidney by HPLC using a Sugar-Pak I column.
Urine osmolality was depressed by furosemide administration from
(mean suM) 2268 187 mOsm/kg in controls to 609 161 after 1 day
and to 426 57 mOsm/kg after 6 days of treatment. When ddAVP was
administered for 120 mm to animals treated chronically with furosemide
urine osmolality rose to 938 242 mOsm/kg. Total organic osmolytes
(sum of glycerophosphorylcholine, betaine, myo-inositol, and sorbitol
concentrations) in the papillary tip decreased from Ill 8 mmollkg wet
wt in controls to 19 2 after 6 days of furosemide. This concentration
did not change (19 4mmol/kg wet wt) after 120 mm of ddAVP despite
a more than twofold increase in urine osmolality. Organic osmolytes in
the renal cortex (5—7 mmol/kg wet wt) were not affected by furosemide
treatment or subsequent ddAVP administration. These data suggest
that prolonged depression of the urinary concentrating mechanism
effectively reduces organic osmoeffectors in the renal papilla to levels
comparable to those in the renal cortex. If, in this situation, urine
osmolality and papillary tonicity rise rapidly, papillary cells adapt
osmotically to the increased tonicity of their surroundings by osmoef-
fectors other than organic osmolytes. These osmoeffectors are probably
inorganic electrolytes.
Potassium channels are responsible for angiotensin II hypersensitivity
and atrial natriuretic factor (ANF) refractoriness of glomeruli from
low-sodium rats. M. Szczepañska-Konkel, M. Redlak, and S. Angielski,
Department of Clinical Biochemistry Medical Academy, Gdañsk, Swit-
zerland. ANF-induced glomerular hyperfiltration is blunted in a low-
sodium (LSD) compared to normal-sodium (NSD) rats. To elucidate the
glomerular refractory to relaxant effect of ANF we investigated the
roles of potassium channels activator (cicletanine) and inhibitor (glib-
enclamid) in angiotensin Il-precontracted glomeruli isolated from low
and normal sodium rats. We have used 3H-inulin method to measure the
extracellular volume of isolated decapsulated glomeruli. The basal
glomerular inulin space (GIS) values were 648 18 and 663 21
pl/glomerulus for NSD and LSD rats, respectively. In response to l0
M angiotensin II (Ang H) the percent reduction of GIS values were
higher in LSD (36%) than in NSD rats (18%). Ang II decreases
glomerular size in vitro, probably reflecting its contraction. ANF (10—v
M) reversed Ang II precontracted glomeruli from NSD rats, but was
without effect on glomeruli from LSD rats. Cicletanine (10 M)
produced complete inhibition of contraction induced by Ang II of
glomeruli from NSD but not from LSD rats. The action of Ang II was
abolished when ANF and cicletanine were added together. Glibencla-
mid (106 M) completely abolished the inhibitory effect of cicletanine
and ANF on Ang Il-induced contraction of glomeruli from LSD rats. In
conclusion our results support the notion that glibenclamid-sensitive
potassium channel is responsible for Ang II hypersensitive contraction
and ANF or cicletanine refractoriness of isolated glomeruli from low
sodium rats.
Correlations between findings in renal biopsy and urinary cytology in
patients with glomerulonephritis (GN). J. Steffgen, S. Bieneck, C.
Grupp, R. Herzog, and H.E. Franz, Department of Nephrology,
University of Ulm, Ulm, Germany. Histological findings of kidney
biopsies in patients with GN often exhibit changes in the following
nephron. This retrospective study inquires what kind of histological
changes of renal tubules cause increased exfoliation of renal tubular
cells (RTC). Papanicolaou-stained urine sediments of 56 patients with
GN (9 membranous, 5 minimal-change, 3 membranoprolif., 8 focal
sclerosis, 16 mesangioprolif., 17 rapid-progressive) at the time of biopsy
were correlated with the following acute and chronic changes: tub.
accumulation of hyalin (AH) N = 19, edema N = 17, necrosis N = 4,
tub. atrophy (TA) N = 38, interst. fibrosis (IF) N = 31, chronic
inflammatory infiltration N = 31 (CII)). We found significantly higher
exfoliation of RTC appearing with AH (median 123 vs. 10, P < 0.01),
edema (med. 105 vs. 16, P < 0.01) and necrosis (med. 81 vs. 14, P <
0.005) calculated by Wilcoxon test for independent samples. Without
significant influence was the appearance of TA, IF and CII. Patients
with histological proven AH had a distinct nephrotic syndrome with
significant reduction of serum albumin (24 vs. 36 g/liter, P < 0.05,
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t-test). This points to the fact that proteinuria might have a tubulotoxic
effect, and can be shown in a higher exfoliation of RTC, which seems to
be linked to acute but not to chronic tubular changes in biopsy.
Expression of probenecid-inhibitable p-aminohippurate transport after
injection of size-fractionated mRNA from rat kidney in Xenopus laevis
oocytes. J. Steffgen, F. Scheyerl, S. Kienle, and H.E. Franz, Depart-
ment of Nephrology, University of Ulm, Ulm, Germany. As the
molecular structure of the p-aminohippurate (PAH) transporter is still
unknown, we used Xenopus oocytes for expression cloning of this
transporter. About 50 ng mRNA from rat kidney were injected per
oocyte. After 3 days of incubation, a 2- to 5-fold stimulation of total
3H-PAH transport was measured in injected oocytes. About 80% of the
expressed transport could be blocked by 5 mr'i probenecid, and more
than 50% of this component were already inhibited by 0.2 mi proben-
ecid. This transport showed a high affinity component for PAH with km
= 0.05 0.01 mM. Preincubation in 1 mi tetrafluor or methylsuccinate
augmented the expressed PAH uptake by about 2.7- or 1.8-fold,
whereas endogenous uptake was not stimulated. Addition of 25 M
ketogluaricacid during uptake inhibited the expressed transport by 38%,
but not the endogenous uptake. This indicates for a counter transport
which also accepts dicarboxylates. Size fractionation of mRNA on a
1.2% agarose gel resulted in a 10-fold uptake stimulation by mRNA of
2—2.8 kb. The data show the expression of a probenecid-inhibitable
PAH-transporter with properties according to data from vesicle exper-
iments.
Expression and characterization of the sodium-dependent dicarboxy-
late transporter after injection of inRNA from rat kidney in Xenopus
laevis oocytes. J. Steffgen, S. Kienle, F. Scheyerl, and N.E. Franz,
Section Nephrology, University of Ulm, Ulm, Germany. Xenopus
oocytes are a widespread in vitro system for expression cloning of
proteins after injection of mRNA. As the sequence of the sodium-
dependent renal dicarboxylate transporter is yet unknown, we injected
50 ng of total mRNA from rat kidney per oocyte and measured uptake
of '4C-succinate after 3 days of incubation. Injected oocytes showed a
2- to 4-fold stimulation of succinate uptake compared to noninjected.
The whole transport was sodium dependent. By varying the concentra-
tions of succinate and sodium we could estimate km values of 25 M
succinate and 20 m sodium. Addition of 10 m lithium decreased the
transport (40-80%). Determination of the substrate affinity of the
expressed transporter showed lacking transport of monocarboxylates,
only little transport of citrate at acid pH and a preference of dicarbox-
ylates with trans- vs. those with cisconfiguration. The results corre-
spond to the characteristics of the basolateral dicarboxylate transport
known from vesicle studies. After size-fractionation of the mRNA on a
1.2% agarose gel this transporter could be expressed by mRNA of 2—3
kb (11-fold stimulation). Our results suggest that the basolateral sodi-
um-dependent dicarboxylate transporter can be expressed by injection
of mRNA from rat kidney in Xenopus oocytes.
Pathogenesis of lupus nephritis: Are histones involved and is there a
cross reaction between heparan sulfate and DNA? F. Stock!, S. Batsford,
S. Muller, T. Schmiedeke, and A. Vogt, Institut für Medizinische
Mikrobiologie, Universiiatsklinik, Freiburg, Germany. The notion that
certain antibodies against DNA can react with epitopes on heparan
sulfate in the GBM and participate in induction of lupus nephritis has
been widely propagated. Recent findings challenge essential details of
this hypothesis. Although monoclonal anti-DNA antibodies bind to the
basement membrane in vitro and in vivo, this cross reactivity largely
disappears when the monoclonal antibodies (Mo Ab) are purified under
dissociating conditions. During production the Mo Ab encounter cell
debris, including DNA-histone complexes (nucleosomes?), which they
can bind via the DNA portion, leaving the highly positive histone
component exposed. This can mediate binding of the Mo Ab-DNA-
histone entity to negatively charged structures like heparan sulfate.
There are a number of observations which speak clearly for participa-
tion of histones in lupus nephritis: 1) histones have a high affinity for the
basement membrane; 2) glomerular deposits of histones could be
detected in murine lupus models. Three mechanisms can be suggested:
1) histones can serve as planted, target antigen, 2) histones mediate
binding of anionic antigens (such as, DNA) by inverting the charge of
the GBM, 3) histones can introduce a further auto-antigen, ubiquitin (a
heat shock protein) into the GBM. We detected glomerular deposits of
histone H3 in 26/39 and histone H2A-ubiquitin in 21/39 lupus biopsies.
The histones must now be assigned a central role in the pathogenesis of
lupus nephritis.
Cellular immunology in patients undergoing chronic hemodialysis. F.
Strutz, T. Risler, K. Haist, C. Boss, C. Erley, D. Skroch, and G.A.
Muller, Medical University Clinic, Department 3, Tubingen, Hospal,
Nflrnberg, Germany. Patients (pts) undergoing chronic hemodialysis
(HD) are more prone to infectious diseases than normals. Beside other
factors the dialysis membrane used seems to affect their immune
response. FACS analyses were performed prior to the HD, and 3, 12,
and 18 months later, using monoclonal antibodies to characterize T, B
cells, macrophages/monocytes, the expression of different MHC class
II antigens and of the IL-2 receptor. The pts were dialyzed either with
a polyacrylonitril (PAN) or a cuprophan (CUP) membrane. Eighty pts
entered the study and 22 pts were analyzed at 12 months. Uremic pts
have high amounts of CD4+ helper T cells and the CD4/CD8 ratio is
about 2.0. There is no significant difference in the T cell subsets
between both groups after 12 months. In both groups, about 40% of the
cells express HLA-DP antigens. However, after 12 months HLA-DP is
expressed on only 33% in CUP pts compared to 44% of the cells in the
PAN group. Moreover, the expression of HLA-DQ seems to be down
regulated in the CUP group, whereas in the PAN group DQ-antigens are
up regulated. There is no difference in the two groups regarding the
expression of the IL-2 receptor molecule. Further extended analysis
will clarify whether the reduction of distinct MHC class H antigens on
immunocompetent cells is restricted to the CUP membrane, which may
be associated with impairments in the antigen presentation.
Erythropoietin induced hypertension is caused by direct vasopressor
effects on renal resistance vessels and is mediated by increased cytosolic
free calcium. M. Tepel, M. Neusser, S. Heidenreich, K.H. Rahn, and
W. Zidek, Medical University-Poliklinik, University of Muenster,
Muenster, Germany. Hypertension caused by erythropoietin (EPO)
therapy of renal anemia is a clinical model of growth hormone-induced
hypertension. The vasopressor effect of EPO on microdissected renal
resistance vessels from normotensive rats was determined in a small
vessel myograph. A dose-dependent vessel contraction after addition of
EPO in concentrations from 10 to 200 U/mi was found. Using 20 U/mI
EPO the active renal vessel wall tension was 0.43 0.05 mM (N 8).
Cytosolic free calcium concentration was measured in cultured vascular
smooth muscle cells from normotensive rats using fura2. The resting
cytosolic free calcium concentration was 85.0 41.2 nM (N = 28). EPO
dose-dependently increased cytosolic free calcium concentration in
smooth muscle cells within 60 seconds by 22.1 25.8 ni at a
concentration of 100 U/mI and by 37.9 14.0 n at 500 U/mI. To
confirm the effect of EPO on calcium hemostasis in humans cytosolic
free calcium concentration was also measured in platelets from nor-
motensive subjects. EPO dose-dependently increased thrombin in-
duced changes of cytosolic free calcium concentration in normotensive
platelets in the concentration range from 5 to 250 U/mI. A maximum
increase of 21% was observed at saturation doses. Using calcium free
medium the effect of EPO on thrombin induced changes could be
attributed to increased release of calcium from intracellular stores. It is
concluded that EPO causes hypertension by elevating cytosolic free
calcium concentration in vascular smooth muscle cells followed by
contraction of resistance vessels.
PAF receptor blocker improves glomerular hemodynamics in rats with
5/6th nephrectomy. F. Thaiss, M.J. Mihatsch, G. Oberle, U. Haber-
stroh, U. Brecht, W. Schoeppe, R.A.K. Stahl, University Hospitals,
Frankfurt, Germany and Basel, Switzerland and Boehringer Ingelheim,
Ingelheim, Germany. To evaluate the role of platelet activating factor
(PAF) in chronic glomerular diseases, rats with 5/6th nephrectomy were
treated with the PAF receptor blocker WEB 2170. WEB 2170 was
started 10 weeks after 5/6th nephrectomy [drinking water (1 g/liter)]. At
the end of the observation period (5 and 9 months after ablation) the
following parameters were examined: albuminuria (Aur: mg/24 hr),
inulin clearance (C1: l/min/100 g body wt), glomerular eicosanoid
formation (TxB2 and POE2: pg/minlmg protein) and morphology. The
results demonstrate that WEB 2170 did not reduce Aur at 5 and 9
months [(5 mon): abi + WEB 67 11, abl 47 14;(9 mon): abl + WEB
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173 28, abl 217 45]. Similarly, C1, and glomerular TxB2 formation
were not influenced by WEB 2170 at 5 months [(C1): Abl + WEB 286
17, AbI 304 50; (TxB2): AbI + WEB 100 17, ABI 114 231. At
9 months after renal ablation, however, C1,, was significantly (P < 0.01)
higher in rats treated with WEB 2170 [(C1,,): abi + WEB 262 22, abl
181 35]. This is accompanied by an increased glomerular PGEZ
formation (P < 0.05) [(PGE2): Abl + WEB 151 25, ABI 101 121 and
unchanged glomerular TxB2 biosynthesis. We conclude that PAF
receptor blockade reduces the progressive decline of C1,, and might
have a beneficial effect in this model of renal disease.
Serotoninergic hepatorenal reflex regulating renal function. E.
Tschernko, I. Ott!, D. Hdussinger, and F. Lang, Institute for Physiol-
ogy, Innsbruck, Austria. According to previous observations from this
laboratory, infusion of 2 mol/min glutamine into the superior mesen-
teric vein leads to a decrease of renal glomerular filtration rate (GFR)
and urinary flow rate (V), whereas infusion of identical amounts of
glutamine into the jugular vein does not significantly alter GFR or V.
The present study has been designed to identify the mechanisms
involved. To this end catheters were placed into the trachea, the right
jugular vein, the superior mesenteric vein, the right femoral artery and
the bladder of anaesthetized male Munich Wistar rats (160—220 g body
wt). The superior mesenteric artery was clamped. Inulin clearance was
taken as a measure of GFR. The animals were infused at a rate of 20
sl/min through the superior mesenteric vein (isotonic saline) and at a
rate of 40 jd/min through the jugular vein (saline + 100 mmol/liter
mannitol). Within 20 mm, the infusion of glutamine (2 prnol/min,
replacing equiosmolar NaCI) into the jugular vein (N = 7) led to a
reduction of GFR by —34 7% and V by —39 7%. Infusion of
identical amounts of glutamine into the jugular vein (N = 4) did not
significantly alter GFR (+2 4%)and V (+2 5%). Spinal transection
at the thoracocervical junction (N = 4) and transection of the hepatic
vagal innervation (N = 4) abolished the effect of mesenteric glutamine
on GFR (+3 9%, and -1-12 13, respectively) and V (-1-18 12 and
—3 9, respectively). Following unilateral renal denervation (N = 5),
the effect of mesenteric glutamine was abolished in the denervated
kidney (GFR: —2 8%, V: —7 8%), but not in the intact kidney
(GFR: —60 6%, V: —56 8%). The effect of mesenteric glutamine
was abolished upon simultaneous infusion of 20 nmol/liter methysergide
(GFR: +5 2%, V: +7 6%, N 6), and is mimicked by mesenteric
infusion of serotonin (GFR: —31 5%, V: —30 4%, N = 8). Taken
together, these observations strongly suggest the existence of a sero-
toninergic hepatorenal reflex decreasing GFR and V.
Magnesium administration prevents the thiazide-induced increase in
osteocyte number in normal dogs. M.C. Faugere, W. Tschope, E. Ritz,
and H.H. Malluche, Division of Nephrology Bone and Mineral Metab-
olism, University of Kentucky, Lexington, Kentucky, USA; Division of
Nephrology University of Heidelberg, Germany. Recently, it has been
suggested that thiazide (THZ) therapy could prevent the decrease in
bone volume in the elderly hypertensive population. Ten years ago, we
found that THZ administration for 3 months in parathyroidectomized
dogs induces an increase in osteocyte (OCY) number without any other
bone changes. The present study evaluates the contribution of parathy-
roid hormone and magnesium (Mg) to the THZ-induced bone changes.
Normal dogs were divided in 3 groups and received (a) THZ, (b) THZ
+ Mg, and (c) placebo. THZ and Mg were given at a dose of 50mg each
for 8 months. No difference in serum PTH levels was found between the
groups. Histomorphometric evaluation of bone did not show any
difference in bone structure, bone formation, resorption and bone
dynamics. The results of the osteocytic parameters are shown below:
THZ + Mg Placebo
Osteocytic index 468 48 318 14 340 19
Osteocytic lacuna area p.m2 30.8 2.2a 22.9 1.2 20.1 1.1
Elliptical ratio 0.42 0.006 0.41 0.006 0.42 0.009
The presence of parathyroid glands does not alter the increase in
osteocytic abnormalities induced by THZ, yet administration of mag-
nesium prevented these bone abnormalities. The mechanism of this
effect and the long-term consequences await further studies.
Combined i.v. iron and ultra low dose erythropoietin (rHuEPO)
therapy in hemodialysis patients. T. Tsobanelis, D. Hoppe, P. Scigalla,
and P. Grützmacher, 2nd Medical Clinic, St. Markus Hospital, Frank-
furt/Main, Boehringer Mannheim, Germany. Development of iron
deficiency has been observed during rHuEPO therapy, preventing from
adequate therapeutic success. We investigated: (1.) the incidence of
functional iron deficiency using a ultra low dose i.v. rHuEPO therapy,
(2.) the response to rHuEPO combined with i.v. iron therapy, (3.)
tolerance of this regimen. Forty HD-pat. without iron deficiency [Hct <
26%, ferritin> 150 pg/liter, transferrin saturation (TFsat) > 20%] were
treated with i.v. rHuEPO (3 x 20 U/kg/wt). Blood cell counts were
controlled weekly and iron status twice monthly. Iron was given iv.
when TFsat was <20% (3 x 40 mg Fe3-gluconate/week, after HD).
Results: 32/40 (80%) pat. developed iron deficiency before reaching the
target Hct (30—35%). Within 6 weeks 19/40 (47.5%) pat., within 12
weeks all 40 pat. reached the target Hct. Despite intensive iv. iron
substitution TFsat remained low without a fall of ferritin. Under
combined i.v. iron and rHuEPO therapy Hct increased by +0.8%/week.
Conclusion: (1.) Even under ultra low-dose rHuEPO functional iron
deficiency develops nearly regularly; (2.) storage iron pool is not
adequately mobilized; (3.) simultaneous i.v. iron and rHuEPO improves
the response to rHuEPO allowing the use of very low doses of EPO
without major side effects.
Stimulation of collagen type IV synthesis by the terminal complement
proteins C5b-9 in human glomerular mesangial cells (GMC) in culture.
Ch. Wagner, B. Jahn, B. Berger, K. Rother, and G. Maria Hansch,
Institut für Immunologie der Universität Heidelberg, Germany. In
many forms of glomerulonephritis C5b-9 is found colocalized with
deposits of extracellular matrix proteins. Since C5b-9 stimulates many
cells, such as to release cytokines or prostanoids, we tested its effect on
the matrix protein synthesis of GMC in culture. Synthesis of collagen
type IV and of fibronectin was measured by Northern blotting or by
biosynthetic labeling with 3H-proline or ELISA, respectively. Two
hours after stimulation with C5b-9 an increase in collagen type IV
specific mRNA was seen; protein synthesis increased up to fivefold
within 24 hours. Since during inflammatory processes complement is
activated by different structures, such as immune complexes, exposed
basement membranes, damaged cells or oxygen radicals, C5b-9 is
constantly generated and may, by modulating collagen synthesis,
contribute to the development of sclerosis.
Response of renin in plasma and kidney to dietary protein in subtotal
nephrectomy. J. Wagner, K. Zeh, S. Bachmann, M. Koller, D. Ganten,
and E. Ritz, Department of Nephrology, University of Heidelberg, and
German Institute of High Blood Pressure Research and Department of
Anatomy, University of Heidelberg, Germany. The renin-angiotensin
system has been implicated in the progression of renal disease. Restric-
tion of dietary protein intake has been shown to be a means to retard the
development of glomeruloscierosis and renal failure. In healthy humans
the plasma renin activity varies with the level of dietary protein. The
interaction between dietary protein intake and the renin-angiotensin
system may therefore be of importance in states of renal disease. To
explore this aspect we examined the effect of a high (40%; HP) and low
(8%, LP) isocaloric protein diet on pairfed sham or subtotally nephrec-
tomized adult Sprague-Dawley rats 3 weeks postoperatively. In sham
operated animals plasma renin activity (PRA) rose with HP to ca. 300
ngAI/ml/hr vs. 110 ngAJJml/hr in LP-animals. In subtotally nephrecto-
mized rats PRA was suppressed to 140 ngAI/ml/hr on HP in contrast to
87 ngAI/ml/hr in the LP group. Plasma prorenin values, however, were
not different in both groups (HP: 13 ngAI/ml/hr vs. 11 ngAI/ml/hr).
These data correspond to renal renin mRNA-expression measured by
RNAse protection assay using $-actin as marker mRNA. In sham
operated animals renal mRNA is increased on HP to 0.72 optical units
vs. 0.40 on LP. In SNX no change is found in response to renal renin
(0.14 vs. 0.15 O.D). In situ hybridization of renal renin mRNA reflected
these results and did not reveal any aberrant renin gene expression.
Dietary protein stimulates PRA in sham and subtotally nephrectomized
animals, however, prorenin and renal renin mRNA does not respond to
high protein intake in subtotally nephrectomized animals.
Demonstration of renin, angiotensinogen and converting enzyme
mRNA expression in human renal biopsies by the polymerase chain
reaction (PCR). J. Wagner, M. Paul, M. KOller, D. Ganten, andE. Ritz,
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Department of Nephrology, University of Heidelberg, and German
Institute for High Blood Pressure Research and Department of Phar-
macology, University of Heidelberg, Germany. A large body of evi-
dence implicates the renin-angiotensin system (RAS) in the progression
of renal disease and glomeruloscierosis by its influence on glomerular
capillary pressure, permselectivity and possibly proliferative effects. In
the kidney it may act independently from the circulatory RAS, since in
the remnant kidney model renal renin mRNA levels are elevated in face
of a suppressed PRA. However, most of the results supporting the role
of the RAS on progression of renal failure have been obtained from
animal models where often extrapolation of results to human renal
disease is difficult due to species-specific differences or the lack of
appropriate animal models. The direct demonstration of mRNA expres-
sion of components of the renal RAS from human renal biopsy
specimens as a sign of local synthesis has been hampered by the low
amounts of tissue available. To obviate these difficulties we employed
the PCR as a highly sensitive method to detect mRNA expression.
Aliquots of routine human renal biopsy specimens were subjected to
mRNA extraction by the LiCI method adapted from Auffray and
Rougeon (1980). Approximately 4 to 10 sg of total RNA could be
recovered from each biopsy. Glyoxalated RNAs were checked on
agarose gels for degradation. For PCR, double-stranded cDNA was
synthesized by reverse transcription of I jg of human renal RNA.
Subsequently, human renin cDNA was amplified by use of two primers
flanking an approximately 380 bp fragment of human renin cDNA
spanning the second and third exon. Angiotensinogen mRNA expres-
sion was determined accordingly as a 240 bp fragment over the fourth
and fifth exon. Two primers spanning a 380 bp region of the human
converting enzyme allowed the detection of human CE-mRNA in the
kidney. Each amplified product was processed by Southern blotting and
hybridization to a nick translated probe. In conclusion, the PCR has
been proven to be a powerful method to demonstrate the components of
the renal RAS from human renal biopsies, Use of PCR techniques
suitable for quantification of mRNA will provide new information about
changes in gene expression of the RAS in human kidney disease.
Expression of IL-1$, PDGF, TGF.J31-fl2, TGF-33 and IFN-y receptor(IFN-R) in IgA-glomerulonephritis (IgA-GN) and in acute renal allograft
rejection. IL. Noronha, H. Weis, M. Rambausek, E. Ritz, R. Wald-
herr, Departments of Pathology and Internal Medicine, University of
Heidelberg, Heidelberg, Germany. Experimental and clinical studies
have stressed the importance of cytokines and growth factors in GN
and in renal allograft rejection. Using monoclonal and polyclonal
antibodies we investigated the presence of IL-lf3, PDGF (A, B),
TGF-f31-f32, TGF-p3 and IFN-yR in 30 biopsies from patients with
IgAGN and in 10 specimens with acute renal allograft rejection by
immuno-cytochemistry (APAAP-method on cryostat sections). The
staining pattern in diseased kidneys was compared with that in normal
renal tissue (N = 5). IL-l/3 positive cells were not detected in normal
human kidneys. A significant number of infiltrating mononuclear cells
expressing IL-1/3 was present in all specimens of acute allograft
rejection, whereas IL-1f3 positive cells were only occasionally observed
in 8/30 cases of IgA-GN. PDGF reactivity was present in mesangial
cells, cells of Bowman's capsule and in arterial endothelial cells in most
specimens examined. Numerous PDGF positive infiltrating cells were
observed in all rejection biopsies. In contrast, only a few cells were
noted in 24/30 biopsies of IgAGN. TGF-/31-/32 and TGF-/33 positivity
was found in mesangial cells, cells of Bowman's capsule and in
endothelial cells. A weak immunostaining of distal tubules was ob-
served in 2/5 normal kidneys with the TGF-13l-132 antibody. TGF-131-132
positivity was noted in proximal and distal tubules in 18/30 biopsies of
IgAGN, and in all rejection cases. TGF-f33 reactivity was increased in
endothelial cells in allograft rejection, and in 27/30 cases with IgAGN.
TGF-/31-f32 and TGF-/33 positive interstitial infiltrating cells were ob-
served, respectively, in 18/30 and 26/30 biopsies with IgAGN, whereas
numerous positive cells were present in rejection biopsies. IFN-7R was
expressed in cells of Bowman's capsule and in distal tubular epithelial
cells, An increased immunoreactivity in proximal and/or distal tubules
was detected in IgAGN (26/30) and in allograft rejection (9/10). IFN-yR
positive interstitial cells were occasionally observed in IgAGN (19/30)
and in all rejection biopsies. In addition, IFN-7R expression in arterial
endothelial cells was present in both conditions. Our results demon-
strate the in situ production of cytokines and growth factors in IgAGN
and in acute allograft rejection supporting the hypothesis that these
factors play an important role in both disorders. In contrast to chronic
IgAGN, in which the expression of these factors at the protein level is
low or only moderately increased, a strong expression is present in
acute allograft rejection reflecting marked immunological activation.
Chronic thromboxane inhibition reduces medial hypertrophy of intra-
renal arteries in rats with renovascular hypertension. U.O. Wenzel, G.
Troschau, U. Helmchen, W. Schoeppe, and G. Schwietzer, Depart-
ments of Medicine and Pathology Universities of Frankfurt am Main
and Hamburg, Germany. Recent studies suggest that enhanced renal
thromboxane (TX) production may play a central role in the pathogen-
esis of renovascular hypertension. Therefore, we studied the effect of a
combined treatment for 6 weeks with the TX receptor blocker Dal-
troban (D) and the TX synthesis inhibitor UK 38.485 (UK) on blood
pressure (BP), albuminuria (ALB), glomerular POE2 production, gb-
merular size (GLOM) and sclerosis (GS), GFR and medial hypertrophy
(MEDIA) of intrarenal arteries in the contralateral kidney of 2 kidney,
I clip Goldblatt hypertension. Treatment was started 6 weeks after
induction of hypertension. Normotensive (NC) and hypertensive (HC)
rats without treatment and a Enalapril treated group (ENP) served as
controls.
HC NC D+UK ENP
BP 192 7 125 3b 171 7 149 8t
MEDIA 4.7 0.4 3.2 0.l' 3.4 0.2 4.6 0.3
POE2 76.3 14 44 5 165 37 100 19
a p < o•o5, b P < 0.01 vs. HC; media thickness calculated according
to Furuyama for a vessel with a radius of 50 pm
BP = mm Hg, MEDIA = l0 mm2, POE2 = (pg/mg protein/mm).
TX inhibition lowered BP to a small extent, decreased MEDIA and
increased glom. POE2 production. There was no effect on ALB,
GLOM, OS and GFR. ENP reduced BP to a greater extent but was
without effect on MEDIA and POE2 production. Conclusion.' These
data demonstrate that TX inhibition may decrease MEDIA of intrarenal
arteries without effect on glomerular function and morphology in the
contralateral kidney of 2K1C hypertension. Since ENP decreased the
BP without effect on MEDIA, local TX and/or POE2 may modulate the
development of MEDIA by direct effects on vascular smooth muscle
growth.
Membrane potential oscillations in Madin-Darby canine kidney
(MDCK) cells transformed by alkaline stress. H.-J. Westphale, B.
GaJiner, and H. Oberleithner, Department of Physiology, University of
Wurzburg, Wurzburg, Germany. Similar to growth factors aldosterone
stimulates plasma membrane Na/H exchange in renal target cells
leading to sustained cytoplasmic alkalinization. An alkaline intracellular
pH reduces the H bonds between repressor proteins and DNA leading
to the destabilization of the nuclear chromatin. We observed that
prolonged alkaline stress per se can lead to malignant transformation of
MDCK cells, which resemble intercalated cells of renal collecting duct.
Cells kept in alkaline (pH 7.8) culture medium for 12 days developed
multiple "foci" composed of spindle-shaped cells lacking contact
inhibition and exhibiting poor adhesion to the culture support, typical
characteristics of dedifferentiated tumor cells. "Foci" cells were cloned
and grown in control medium, pH 7.4. Cells maintained their malignant
features, indicating stable pH-induced genetic transformation. Cells
were fused with polyethylene glycol to giant cells and impaled with
microelectrodes. In contrast to non-transformed giant MDCK cells the
plasma membrane potential showed spontaneous hyperpolarizing
spikes with a frequency of I .8/mm and an amplitude of more than —7
mV. Superfusion with Ca2-free Ringer's solution resulted in a dra-
matic decrease of the frequency (to 0.7/mm) and in a reduction of the
hyperpolarization amplitude (to —0.9 mV). Treatment with 10 mmol/
liter Ba2, a K channel blocker, led also to a clear decrease in the
amplitude (to —1.6 mV) while the frequency of the spontaneous plasma
membrane potential oscillations remained virtually constant. We con-
clude that sustained alkaline stress can induce malignant transformation
in MDCK cells indicated by an abnormal growth pattern and by the
appearance of instable Ca2-activated K channels.
Tissue distribution of neutrophils in postischemic acute renal failure.
CC. Willinger, H. Schramek, K. Pfaller, and W. Pfaller, Institute of
Physiology, University of lnnsbruck, Innsbruck, Austria. Polymorpho-
nuclear neutrophils (PMNs) are assuced to cause oxygen radical-
induced cell injury via lipid peroxidation, neutrophil enzymes and
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cicosanoids, and thereby to trigger decrease in GFR. They further could
amplify reperfusion injury induced by other cellular sources of oxygen
radicals such as epithelia or endothelia. Furthermore, capillary plugging
by PMNs might induce microcirculation disturbances and vasoconges-
tion. The aim of the present study was to gain additional insight into the
pathogenetic potential of PMNs during postischemic acute renal failure
(ARF) in the rat by quantifying the intrarenal PMN distribution within
the first two hours of reperfusion: Following 45 minutes of renal artery
clamping PMN distribution was studied histochemically at 0, 5, 20 and
120 minutes after starting reperfusion on independent cortico-medullary
sections. Neutrophil counts per unit section area were obtained for
renal cortex, outer (OM) and inner medulla (IM). Cortical counts were
subdivided into intraglomerular and peritubular, outer medullary counts
into outer (OSOM) and inner stripe (ISOM).
Control 0 mm 5 mm 20 mm 120 mm
Total 54 8 88 14 94 6 112 14 487 63
Cortex 66 3 136 22 97 6 123 11 554 19
Intraglomer. 44 4 100 15 70 6 65 9 196 19
Pentubular 23 4 36 8 27 2 58 3 358 48
OM 36±8 32± 10 76±4 85± 19 416±99
OSOM 13±5 6±1 24±3 21±5 175±47
ISOM 82 15 83 24 197 23 242 58 944 207
IM 31 12 65 7 199 58 416 30
With respect to the localization of PMNs no clear cut extravasation
could be found in any of the reperfusion intervals studied. These results
are in distinct contradiction to the findings of Hellberg et al, 1989, 1990,
who reported extremely low numbers of PMNs in renal medulla and
high PMN numbers in glomeruli. Our present study, however, demon-
strates PMN counts of comparable order of magnitude for each of the
three zones, with the highest counts in the ISOM and increased
numbers in the peritubular instead of glomerular regions. Interestingly,
there is a drastic increase of inner strip PMNs during the first 5 mm of
reperfusion. This early increase as well as the marked accumulation of
PMNs within the inner stripe of the outer medulla is consistent with the
hypothesis of vasocongestion as a causal mechanism in the early phase
of ARF. Further studies are necessary to evaluate conclusively whether
PMNs can be held responsible for vasocongestion by capillary plugging,
although the possibility must be kept in mind that PMN accumulation
might be just a side effect of vasocongestion. Nevertheless, the steadily
increasing number of PMNs during reperfusion of the ischemic rat
kidney may be considered causative for the maintenance of postisch-
ernie ARF.
Non-occlusive mesenteric obstruction—NOMI in hemodialysis patients;
risk factors, consequences and outcome. M. Zeier, St. Geberth, M.
Rambausek, Th. Hupp, and E. Ritz, Departments of Medicine and
Surgery, University of Heidelberg, Heidelberg, Germany. With the
change in the demography of dialysis patients (pts.) NOMI has become
increasingly prevalent. We report on our experience from 1/89—8/90 in
which we observed 7 cases of NOMI among 200 dialysis pts. The pts.
who had NOMI had a median age of 52 years (range 34—65) the average
dialysis population 54 years (range 27—79). All pts. with NOMI were
male (113 male; 87 female in overall dialysis population) and 6/7 had
peripheral occlusive disease, myocardial ischemia or both. Only 1 pt.
was diabetic, none was on digitalis or had atrial fibrillation. Average
duration of dialysis was 4.2 years (1—8) versus 5.9 years (1—21) in the
overall dialysis population. Risk factors were smoking (4/7) dialysis
hypotension (5/7) and extramesenteric atherosclerosis (7/7). Outcome:
5/7 pts. required surgery, 4 pts. died in the postoperative period, one
after 6 months. One pt. had cholesterol embolism after an intramesen-
teric infusion of vasodilators. Our experience suggests a trend for
increased prevalence of NOMI. Risk factors are extramesenteric ath-
erosclerosis, hypovolemia and/or intradialytic hypotension. Conclu-
sions: (i) Hypovolemia and dialysis hypotension must be avoided in pts.
with diffuse atherosclerosis; (ii) immediate angiography should be
performed when NOMI is suspected; (iii) prognosis remains poor
despite early intervention.
Renal function, circulatory parameters and proteinuria in living-
related kidney donors before and after exercise. Chr. Blaser, J.E.
Scherberich, E. Scheuermann, W. Ernst, W. Schoeppe, Department of
Medicine, University of Frankfurt/M., Frankfurt am Main, Germany.
We investigated possible changes of renal function (Ccr), routine blood
parameters, blood pressure and the excretion of tubular enzymes and
serumjroteins after unilateral nephrectomy of 33 related donors (20 f,
13 m, x 5.35 years after nephrectomy) before and after a standardized 6
mm exercise. For comparison, we examined 28 healthy persons with
two kidneys (17 f, II m) in the same manner. Two urine samples of
collecting periods of 1 hr, one before and one after exercise, were
analyzed. The kidney size and the diameter of the parenchyma,
measured by ultrasound, were larger in the nephrectomized patients (2P
<0.05—0.001); the median of serum creatinine was higher (2P < 0.001),
the endogenous creatinine clearance lower (2P < 0.01), serum K,
Ca and glucose concentrations were higher (2P < 0.01), all within
normal limits, however. After exercise the donors had higher excretion
rates for albumin, alpha-l-microglobulin and 13-NAG, with a positive
correlation between /3-NAG and albumin excretion (calculated as
protein/creatinine index, 2P < 0.05). After 6 mm of exercise and after 5
mm of regeneration the heart rate of the donors was significantly higher
compared to the controls, as was the blood pressure before and after
exercise (2P < 0.05—0.01). The protein excretion patterns (SDS-PAGE)
showed more protein bands in the donors' specimens versus control
after exercise. These data evidence changes of renal function and
protein handling in the kidney donor group under exercise compared to
the controls, apparently reflecting adaptive responses which were all
within physiological ranges.
Endotoxin increases intraglomerular resistance: Roles of prostaglan-
dins and PAF. H.A. Bock, M. Hermie, V. Muller, F.P. Brunner, and G.
Thiel, Nephrology Division, Kantonsspital Base!, Switzerland. Endo-
toxin induced contraction of the mesangium may be a cofactor in the
pathogenesis of septicemic renal failure (SRF). We used the isolated
perfused glornerulus technique to directly investigate the endotoxin
effect on glomerular microcirculation. Single, microdissected rabbit
glomeruli were perfused through the afferent arteriole while keeping
intraglomerular pressure at the capillary branching point constant at 40
2 mm Hg. Glomerular resistance (Rom) and glomerular volume
(Vgjom) were determined in 20 mm intervals. After two control periods
(Con. 1/2), Pseudomonas endotoxin (60 g/ml) was added to the perfu-
sion solution for 3 x 20 mm (Exp. 1—3). Since several studies suggest a
role for vasoconstrictor prostaglandins or platelet activating factor
(PAF) in the pathogenesis of SRF, endotoxin was also perfused with the







Rgiom Vgiom Rgom Vgiom
Con.l 38±4 100±1 32±5 99±1
Con. 2 45 6 100 1 31 5 101 1
Exp.1 52±6 99±2 34±6 98±2
Exp. 2 62 9 93 3 34 5 102 3





Rgiom V510, Rgiom V,,,
Con. 1 50 11 99 1 44 4 101 1
Con.2 49±8 101±1 42±4 99±1
Exp.l 48±8 99±1 39±4 101±2
Exp.2 53±11 99±1 35±4 102±1
Exp. 3 47 10 99 1 36 6 101 2
Data are mean SEM. Rgiom: mm Hg/d/min; Vom: % of Con. 1/2.
a P < 0.05 vs. Con. 1/2
Conclusions: (I.) Endotoxmn perfusion increases glomerular resistance
and decreases glomerular volume. (2.) Since efferent arteriolar constric-
tion would increase glomerular volume, the resistor has to be intraglo-
merular. The most likely mechanism, therefore, is mesangial contrac-
tion. (3.) The contracting effect of endotoxin within the glomerulus
appears to be mediated by release of prostaglandins (Thromboxane
A2?) and PAF.
